Alzheimer disease, including avohilmo

G6_ALZHEIMER_INCLAVO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G30 1 out of 7 registries used, show all original rules.	11197
4. Check minimum number of events None	11197
5. Include endpoints G6_ALZHEIMER	20029
6. Filter based on genotype QC (FinnGen only)	19443

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	G6_ALZHEIMER_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_ALZHEIMER
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G30
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer disease, including avohilmo based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	19443	9475	9968
Unadjusted period prevalence (%)	3.98	3.36	4.57
Median age at first event (years)	80.32	80.33	80.31

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17765: Matched controls
125070

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

321.2

4174

15989

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

106.9

317.0

225

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

310.3

4077

15654

F03

ICD-10 Finland

Unspecified dementia

6.7

307.7

3119

3853

N06DA03

ATC

rivastigmine; oral, transdermal

32.8

307.7

5184

1550

R41.3

ICD-10 Finland

Other amnesia

5.6

307.7

1426

1924

N06DA02

ATC

donepezil; oral

60.5

307.7

8332

1800

SPAT1216

SPAT

Assessment of functional ability

2.4

307.7

4870

16855

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

62.9

307.7

4281

628

P20

ICPC

Memory disturbance

9.1

307.7

9333

13563

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

59.4

307.7

564

F06.7

ICD-10 Finland

Mild cognitive disorder

5.1

307.7

1510

2241

F009, G309,

ICD-10 Finland

3005.4

307.7

424

G30

ICD-10 Finland

Alzheimer disease

+∞

307.7

1466

N05AH04

ATC

quetiapine; oral

3.8

307.7

3805

8409

SPAT1053

SPAT

Memory test

4.0

307.7

7079

17686

P70

ICPC

Dementia

22.5

307.7

2303

823

F05.1

ICD-10 Finland

Delirium superimposed on dementia

13.2

307.7

508

278

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

90.7

307.7

5361

593

SPAT1245

SPAT

Provision of support and information to patient’s family members

4.3

307.7

2078

3734

N06DA04

ATC

galantamine; oral

24.4

307.7

2534

847

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

5425

21152

G30.1

ICD-10 Finland

Alzheimer disease with late onset

+∞

307.7

10839

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

62.1

307.7

817

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

31.4

307.7

2552

665

A28

ICPC

Limited function/disability NOS

2.9

307.7

6508

20576

N06DX01

ATC

memantine; oral

87.5

307.7

10838

2197

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

307.7

7235

32706

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.2

307.7

3283

8380

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

87.4

307.7

1397

122

N05AX08

ATC

risperidone; systemic

9.5

307.7

4793

4671

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

+∞

307.7

5346

WYA20

NOMESCO Finland

Home visit

6.8

307.7

870

946

N05BA04

ATC

oxazepam; oral

2.1

307.7

5254

21022

SPAT1234

SPAT

Support of social functional capacity

3.2

307.7

1865

4442

G30.0

ICD-10 Finland

Alzheimer disease with early onset

+∞

307.7

1205

F0019, G301,

ICD-10 Finland

+∞

307.7

705

G30.8

ICD-10 Finland

Other Alzheimer disease

+∞

307.7

3293

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

190.0

307.7

725

SPAT1254

SPAT

Administration of medicine

2.2

307.7

3852

14261

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.7

307.7

5282

7401

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.9

307.7

2387

6459

R41.0

ICD-10 Finland

Disorientation, unspecified

3.5

304.7

1213

2542

TAB00

NOMESCO Finland

Lumbar puncture

4.2

292.8

896

1545

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

273.8

5038

21631

AXX01, ,

SPAT

3.6

272.4

1067

2208

N06AX26

ATC

vortioxetine; oral

3.6

270.9

1061

2195

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

5.3

269.3

628

852

AA1AD

NOMESCO Finland

CT of head and brain

1.8

266.5

6345

29484

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

81.2

266.4

194

N06AX11

ATC

mirtazapine; oral

1.8

262.3

5929

27091

N03AG01

ATC

valproic acid; systemic, rectal

3.3

254.9

1115

2481

A04

ICPC

Weakness/tiredness general

2.0

237.6

3266

12601

L28

ICPC

Limited function/disability (L)

1.8

232.8

4525

19596

F00

ICD-10 Finland

Dementia in Alzheimer disease

18.6

222.1

224

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.6

206.5

1454

4217

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

76.6

206.0

151

N05AH03

ATC

olanzapine; systemic

3.3

203.0

890

1978

F0009, G300,

ICD-10 Finland

+∞

202.4

223

N06AB10

ATC

escitalopram; oral

2.0

195.2

2455

9111

SPAT1101

SPAT

Orthostatic test

2.5

183.7

1395

4188

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

179.1

6245

31338

N05AD01

ATC

haloperidol; systemic

3.0

173.1

886

2161

U04

ICPC

Incontinence urine

2.3

172.7

1466

4628

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

41.9

169.7

136

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.0

163.6

537

974

N02BE01

ATC

paracetamol; systemic, rectal

1.8

162.1

15015

94129

N02AA05

ATC

oxycodone; systemic

1.7

161.7

4138

19081

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

161.5

626

1280

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.2

160.0

492

848

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

159.6

1351

4254

Z75.5

ICD-10 Finland

Holiday relief care

4.9

157.1

399

585

SPAT1301

SPAT

No procedures

1.6

156.2

6097

31167

A06AD11

ATC

lactulose; oral

1.7

154.9

3861

17647

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.0

150.6

2103

8050

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

149.7

2256

8861

F0029, G308,

ICD-10 Finland

+∞

149.7

165

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

146.6

1234

3871

A29

ICPC

General symptom/complaint other

1.8

145.9

2606

10802

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

142.6

3143

13849

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.6

140.4

895

2457

SPAT1252

SPAT

Overall medication plan or its review

2.0

137.7

1691

6172

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

137.0

2601

10963

S01.0

ICD-10 Finland

Open wound of scalp

2.0

136.8

1693

6197

F0014, G301,

ICD-10 Finland

368.4

135.8

156

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

135.0

1179

3756

F001, G301,

ICD-10 Finland

141.2

131.6

159

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

130.5

1163

3735

F21, ,

ICPC

4.7

130.4

348

533

R55

ICD-10 Finland

Syncope and collapse

1.8

129.2

2592

11087

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

5.3

127.2

293

392

SPAT1360

SPAT

Extensive global examination

2.0

124.6

1541

5631

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

65.8

124.5

130

Kela drug reimbursment

Malignant tumour

0.3

121.4

442

8958

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

114.7

1966

8003

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

114.6

3280

33066

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

4.4

114.4

325

525

F05.9

ICD-10 Finland

Delirium, unspecified

2.8

113.0

646

1672

S06.0

ICD-10 Finland

Concussion

1.8

110.3

1826

7348

SPAT1229

SPAT

Assessment of need for aid

1.8

110.0

1890

7692

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

100.8

3174

15164

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

98.8

1277

4725

H02AB02

ATC

dexamethasone; systemic

0.4

98.6

505

8793

N27

ICPC

Fear of neurological disease other

3.2

98.5

435

968

SPAT1139

SPAT

Nutrition survey

2.4

97.8

736

2187

R42

ICD-10 Finland

Dizziness and giddiness

1.5

93.6

4568

23900

S70.0

ICD-10 Finland

Contusion of hip

2.2

92.1

897

2981

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

89.9

1090

13879

SPAT1050

SPAT

Extensive neurological examination

2.8

88.3

490

1247

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

28.3

86.6

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

47.3

85.3

W19

ICD-10 Finland

Unspecified fall

1.7

82.6

1798

7800

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

4.8

77.8

198

291

SPAT1172

SPAT

Guidance concerning hydration

2.3

77.6

676

2142

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

77.1

2008

9115

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.4

77.0

583

1736

Z29

ICPC

Social problem NOS

3.0

76.0

383

923

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

75.2

N06AB06

ATC

sertraline; oral

1.8

74.3

1201

4772

N06AB04

ATC

citalopram; systemic

1.5

74.1

3131

15813

C10AA01

ATC

simvastatin; oral

1.3

74.0

9228

55829

E86

ICD-10 Finland

Volume depletion

2.3

74.0

638

2013

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.3

73.8

312

675

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

73.2

3183

16165

AA1AD, ,

SPAT

8.5

71.7

110

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

70.3

1819

19133

AXX01

NOMESCO Finland

Memory assessment

9.8

69.9

N05AD03

ATC

melperone; systemic

3.0

68.2

338

807

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

68.0

1207

4930

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

9.0

66.2

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

66.1

5043

28182

F0011, G301,

ICD-10 Finland

184.2

65.9

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

63.8

1141

4669

N30.0

ICD-10 Finland

Acute cystitis

1.5

63.2

2706

13655

SPAT1251

SPAT

Organisation of medication

2.0

62.9

775

2811

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

62.4

575

1865

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.1

61.0

638

2177

IHZ08, ,

SPAT

9.5

60.2

ICB01, ,

SPAT

6.3

59.4

116

131

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.6

59.3

1456

6490

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

32.1

58.8

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

58.7

3565

32164

OAB76

NOMESCO Finland

General guidance on nutrition and food

12.7

58.6

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

58.6

1302

5657

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

58.5

1515

6842

A27

ICPC

Fear of other disease NOS

1.9

58.5

869

3357

N07AA05, ,

ATC

125.5

58.5

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

57.8

931

3689

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

11.9

57.6

G04CA02

ATC

tamsulosin; oral

1.3

57.4

5332

30547

WX402

NOMESCO Finland

General anaesthesia

0.6

57.3

1202

13337

G04CB01

ATC

finasteride; oral

1.4

57.3

2864

14851

A04AA02

ATC

granisetron; systemic, transdermal

0.3

55.3

210

4227

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.7

54.0

2579

24263

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.3

53.9

462

1453

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

53.9

696

2565

SPAT1263

SPAT

Sampling

1.3

53.0

6517

38678

SPAT1167

SPAT

Insertion of urinary catheter

1.8

52.4

800

3115

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.3

52.3

447

1405

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

52.0

2281

11528

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

51.2

1511

7029

F002, G308,

ICD-10 Finland

58.3

50.1

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

3.9

49.9

162

292

F0024, G308,

ICD-10 Finland

+∞

49.8

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

205.8

49.4

J01CA08

ATC

pivmecillinam; oral

1.3

49.2

5624

32974

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.3

48.9

106

2871

W0A10

NOMESCO Finland

Mapping of psychosocial situation

8.4

48.8

WZC30

NOMESCO Finland

Teaching

0.6

48.7

1121

12207

XF606, ,

SPAT

3.9

48.4

158

286

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

48.4

108

2877

P05

ICPC

Senility, feeling/behaving old

3.7

48.3

172

332

N17

ICPC

Vertigo/dizziness

1.4

47.1

2181

11118

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

47.0

4832

27899

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

23.3

46.2

AA1CG, ,

SPAT

3.9

44.9

149

273

SPAT1014

SPAT

Treatment of eyes

2.3

44.7

382

1200

G31.0

ICD-10 Finland

Circumscribed brain atrophy

4.1

44.5

137

237

R33

ICD-10 Finland

Retention of urine

1.5

44.4

1832

9131

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

44.2

797

3263

R1250

NOMESCO Finland

Evaluation of functional capability

2.4

44.2

317

921

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

14.4

43.7

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.0

43.5

521

1870

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

43.3

5044

29532

A10AB05

ATC

insulin aspart; parenteral

1.6

43.2

1200

5498

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

43.1

2582

13743

F01.2

ICD-10 Finland

Subcortical vascular dementia

3.4

42.9

171

357

J01DB01

ATC

cefalexin; oral

1.3

42.6

12328

80177

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

42.3

2303

21342

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

42.2

775

3190

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

42.0

1589

7780

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

41.8

1632

8042

R5110, ,

SPAT

1.6

41.7

1200

5540

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

41.7

1488

14836

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

41.1

2326

12256

Z28

ICPC

Limited function/disability (Z)

3.8

40.3

138

259

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.0

40.1

453

1591

F0012, G301,

ICD-10 Finland

323.7

40.0

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

53.5

39.8

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

39.4

2599

14029

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.4

39.2

287

842

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

20.6

39.2

A04AA01

ATC

ondansetron; systemic, rectal

0.5

39.0

412

5552

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

4.1

38.4

117

201

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

38.2

1754

16747

-2, ,

ICPC

3.4

38.0

153

322

R1250, ,

SPAT

2.4

37.9

293

882

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

37.8

1424

6961

LAITO, ,

NOMESCO Finland

8.8

37.6

SPAT1284

SPAT

Extensive health certificate

2.2

37.4

357

1175

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

37.0

413

1445

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

36.7

5231

31234

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

105.9

36.7

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

44.1

36.5

J01EA01

ATC

trimethoprim; systemic

1.3

36.3

4325

25276

N28

ICPC

Limited function/disability (N)

2.3

36.0

310

978

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.7

35.4

738

3146

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.3

35.3

300

942

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

10.0

35.0

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

34.9

251

3859

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

34.8

3373

28968

JN4AD

NOMESCO Finland

Body CT examination

0.6

34.7

847

9143

XX3DW

NOMESCO Finland

Time consuming IT work

0.6

34.5

791

8662

F22.0

ICD-10 Finland

Delusional disorder

2.5

34.1

226

633

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

33.4

143

2724

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

5.0

33.3

115

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

32.8

148

2754

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

32.7

1793

9377

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.1

32.2

330

1118

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

32.1

421

1560

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

32.0

1652

15520

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

259.8

32.0

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.7

32.0

1812

16780

EB1VA, ,

NOMESCO Finland

0.6

31.8

500

6008

L01BC06

ATC

capecitabine; oral

0.4

31.8

139

2621

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

31.6

6067

37250

L89

ICD-10 Finland

Decubitus ulcer and pressure area

1.9

31.6

412

1524

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

31.5

1661

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

31.4

1039

4941

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

31.1

1683

8779

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.8

30.6

478

1875

WX212

NOMESCO Finland

Femoral plexus blockade

1.9

30.6

439

1677

D12

ICPC

Constipation

1.7

30.4

655

2816

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

30.2

1037

4970

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

30.0

6787

42292

F0022, G308,

ICD-10 Finland

+∞

29.9

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

29.7

1102

5364

HA1RA, ,

SPAT

0.2

29.7

1680

SPAT1262

SPAT

Handing over of treatment supplies

1.3

29.7

2896

16451

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.6

29.6

730

7876

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

29.6

357

1286

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.6

29.3

107

211

F0021, G308,

ICD-10 Finland

238.5

29.3

C10AX09

ATC

ezetimibe; oral

0.7

29.1

1340

12840

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

29.0

2393

13291

F05.8

ICD-10 Finland

Other delirium

2.6

29.0

175

468

N29

ICPC

Neurological sympt/complt other

2.0

29.0

318

1107

A10AE04

ATC

insulin glargine; parenteral

1.4

28.9

1472

7596

F01.9

ICD-10 Finland

Vascular dementia, unspecified

1.8

28.7

431

1671

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.6

28.4

793

3632

Z2445

NOMESCO Finland

Psychologist

2.2

28.2

270

891

EB4VA, ,

NOMESCO Finland

0.5

28.2

225

3333

WYA20, ,

SPAT

3.3

27.7

114

244

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

27.6

367

1368

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

4.1

27.5

145

F0013, G301,

ICD-10 Finland

224.3

27.5

A01

ICPC

Pain general/multiple sites

1.4

27.5

1356

6956

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

27.2

1103

10808

E0000UV, ,

ATC

1.2

26.8

5707

35242

M01AH05

ATC

etoricoxib; oral

0.8

26.5

5795

46015

R11

ICD-10 Finland

Nausea and vomiting

1.4

26.4

1269

6482

S28

ICPC

Limited function/disability (S)

2.8

26.3

147

378

N02AX02

ATC

tramadol; systemic, rectal

0.8

26.2

5319

42540

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

26.1

1923

10505

W06

ICD-10 Finland

Fall involving bed

2.4

26.0

190

559

F00, F03,

ICD-10 Finland

6.8

26.0

P29

ICPC

Psychological sympt/compl other

1.8

25.9

402

1575

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

25.8

666

2995

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

25.7

498

2081

C03DA01

ATC

spironolactone; oral

0.7

25.5

1507

13907

H02AB06

ATC

prednisolone; systemic

0.8

25.2

6069

47854

F0024, G301,

ICD-10 Finland

205.5

24.8

SPAT1153

SPAT

Removal of sutures

0.8

24.8

3830

31484

F009, F03,

ICD-10 Finland

9.1

24.8

G04CB02

ATC

dutasteride; oral

1.3

24.6

1561

8339

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

4.6

24.3

Y94.0

ICD-10 Finland

Accident at home

1.9

24.2

321

1196

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

24.2

408

1640

G04BD08

ATC

solifenacin; oral

1.4

23.9

1207

6214

S01BC05

ATC

ketorolac; ophthalmic

1.5

23.8

827

3971

C03CA01

ATC

furosemide; systemic

1.2

23.8

7438

47378

A78

ICPC

Infectious disease other/NOS

2.4

23.7

168

487

Y94.1

ICD-10 Finland

Accident in connection with service housing

6.7

23.7

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

23.7

215

696

E000001, ,

ATC

1.3

23.6

2533

14518

SDA03

NOMESCO Finland

Periodontal treatment

0.8

23.5

2868

24183

W0A10, ,

SPAT

10.4

23.3

A10BK03

ATC

empagliflozin; oral

0.7

23.3

680

7088

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.7

23.2

410

1671

SPAT1285

SPAT

Provision of consultation response

1.5

23.1

781

3729

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.2

23.1

218

Z60.8

ICD-10 Finland

Other problems related to social environment

3.8

23.1

146

TQW40, ,

SPAT

0.6

23.0

370

4423

Z03

ICPC

Housing/neighbourhood problem

2.9

22.8

116

283

P04

ICPC

Feeling/behaving irritable/angry

4.7

22.8

F0004, G300,

ICD-10 Finland

+∞

22.6

F009, G301,

ICD-10 Finland

+∞

22.6

K59.0

ICD-10 Finland

Constipation

1.4

22.6

995

5000

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

29.1

22.4

L03AA13

ATC

pegfilgrastim; parenteral

0.4

22.3

152

2384

T03

ICPC

Loss of appetite

3.6

22.2

157

WF002

NOMESCO Finland

Radical radiotherapy

0.6

22.1

377

4439

C10AA07

ATC

rosuvastatin; oral

0.8

22.1

3290

27205

SPAT1236

SPAT

Informing family of child’s disability

1.9

22.1

304

1148

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

5.4

22.0

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.1

22.0

228

778

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

22.0

621

2852

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

21.9

1775

N07AA06, ,

ATC

+∞

21.7

R06.0

ICD-10 Finland

Dyspnoea

0.8

21.6

3466

28469

L75

ICPC

Fracture: femur

1.9

21.6

276

1016

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.0

21.6

105

250

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

21.5

769

7715

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

21.3

567

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

21.2

442

1886

KMAK, ,

NOMESCO Finland

1.2

21.1

5475

34226

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

21.1

172

2525

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

91.7

21.1

WW500

NOMESCO Finland

Blood transfusion

0.5

20.9

232

3081

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

2.9

20.9

109

270

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

20.9

695

3308

Z51.88

ICD-10 Finland

Other specified medical care

1.8

20.8

319

1247

J01MA02

ATC

ciprofloxacin; systemic

1.2

20.7

6411

40646

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

4.7

20.5

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

20.4

134

2130

F0023, G308,

ICD-10 Finland

169.2

20.4

P28

ICPC

Limited function/disability (P)

3.1

20.4

217

T08

ICPC

Weight loss

1.9

20.3

250

910

XF600, ,

SPAT

1.7

20.2

412

1747

T05

ICPC

Feeding problem of adult

3.0

20.2

226

H02AA02

ATC

fludrocortisone; oral

2.3

20.1

167

521

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.9

20.1

284

1082

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.8

20.0

344

1391

SPAT1125

SPAT

Stoma care and guidance

1.7

20.0

350

1424

A98

ICPC

Health maint/preventive medicine

1.2

20.0

13970

94345

G04BD12

ATC

mirabegron; oral

1.3

19.9

2099

11987

S01.8

ICD-10 Finland

Open wound of other parts of head

2.0

19.9

220

770

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

19.9

885

K08.3

ICD-10 Finland

Retained dental root

1.4

19.8

1007

5188

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.9

19.7

263

983

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.0

19.7

219

768

ZXY02

NOMESCO Finland

Neuropsychologist

4.4

19.6

N03AX14

ATC

levetiracetam; systemic

1.7

19.5

352

1444

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

162.1

19.5

AA1BG, ,

SPAT

2.2

19.4

164

516

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

19.4

1307

11872

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.3

19.4

1721

9624

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.7

19.3

367

1529

M04AA01

ATC

allopurinol; systemic

0.8

19.3

1868

16207

SPAT1104

SPAT

Monitoring of emergency patient

1.4

19.2

993

5132

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

19.1

695

6954

R54

ICD-10 Finland

Senility

2.4

19.0

137

402

U28

ICPC

Limited function/disability (U)

2.0

18.9

205

713

A04AA55

ATC

palonosetron, combinations; systemic

0.3

18.7

1175

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

3.1

18.7

184

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

18.6

1139

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

18.6

1947

16751

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

18.6

7772

50290

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

5.3

18.5

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

18.5

950

R03AC02

ATC

salbutamol; inhalant

0.9

18.4

6032

46803

A10BJ06

ATC

semaglutide; parenteral

0.4

18.4

115

1861

K59.09

ICD-10 Finland

Constipation, unspecified

1.3

18.3

1133

6024

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.0

18.2

208

738

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

4.0

18.2

XQ858, ,

SPAT

3.3

18.1

162

Z75.0

ICD-10 Finland

Medical services not available in home

3.5

17.9

132

G47.3

ICD-10 Finland

Sleep apnoea

0.8

17.8

1599

14005

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

17.7

6521

41746

SPAT1260

SPAT

Consultation of another employee

1.2

17.7

2598

15373

B01AB10

ATC

tinzaparin; parenteral

0.7

17.7

767

7449

A10BB12

ATC

glimepiride; oral

1.3

17.6

1446

8001

A10BK01

ATC

dapagliflozin; oral

0.7

17.4

459

4890

C04AE01

ATC

ergoloid mesylates; systemic

2.2

17.4

158

513

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

17.3

2417

14230

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

17.2

150

2150

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

17.1

107

1730

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

17.1

1437

12694

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

17.1

2407

20089

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.8

17.1

253

980

G72.8

ICD-10 Finland

Other specified myopathies

1.8

17.0

275

1094

R32

ICD-10 Finland

Unspecified urinary incontinence

1.6

16.9

457

2080

R01AD58

ATC

fluticasone, combinations; nasal

0.8

16.9

1131

10289

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.8

16.8

1450

12773

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

16.8

1870

10736

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

16.8

1552

8717

ZXA00

NOMESCO Finland

Right side

1.2

16.8

4406

27462

I67.4

ICD-10 Finland

Hypertensive encephalopathy

5.7

16.8

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.7

16.7

437

4662

ZX120

NOMESCO Finland

Intravenous

0.7

16.6

789

7553

N99

ICPC

Neurological disease other

2.1

16.6

173

593

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.8

16.6

105

S09.9

ICD-10 Finland

Unspecified injury of head

1.9

16.6

212

783

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.1

16.5

6966

44972

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

16.4

503

5197

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

16.3

296

3429

F0019, G309,

ICD-10 Finland

+∞

16.3

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.6

16.3

343

3835

G04BD07

ATC

tolterodine; oral

1.4

16.2

917

4807

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.4

16.1

749

3802

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.6

16.1

222

2760

A10BH05

ATC

linagliptin; oral

1.3

16.0

960

5079

D82

ICPC

Teeth/gum disease

0.8

16.0

2586

21318

XF606

NOMESCO Finland

Ortostatic test

2.2

15.9

138

440

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

15.9

338

3772

F32

ICD-10 Finland

Depressive episode

1.6

15.9

371

1632

P18

ICPC

Medication abuse

3.6

15.9

112

R44.1

ICD-10 Finland

Visual hallucinations

2.5

15.9

109

313

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

15.9

108

1689

U13

ICPC

Bladder symptom/complaint other

1.6

15.9

439

2010

XQ855, ,

SPAT

2.3

15.8

125

383

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

15.8

1264

L03AA02

ATC

filgrastim; parenteral

0.5

15.7

114

1741

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

15.7

2239

13198

L15

ICPC

Knee symptom/complaint

0.8

15.7

2285

19027

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

15.6

1287

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.5

15.6

108

1677

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

15.6

2390

14191

S22.3

ICD-10 Finland

Fracture of rib

1.3

15.3

951

5058

R45.5

ICD-10 Finland

Hostility

7.7

15.3

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.6

15.2

240

A99

ICPC

Disease/condition unspecnature/site

1.3

15.1

1299

7227

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.0

15.1

177

635

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.4

15.1

603

2980

G04CA01

ATC

alfuzosin; oral

1.2

15.0

2116

12460

E66.01

ICD-10 Finland

Obesity due to excess calories

0.6

15.0

237

2839

SPAT1058

SPAT

PEF monitoring instruction

0.7

14.9

638

6212

Z51.5

ICD-10 Finland

Palliative care

1.3

14.9

1503

8530

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

14.8

169

2220

N80

ICPC

Head injury other

1.8

14.8

243

972

Z01.2

ICD-10 Finland

Dental examination

0.9

14.8

3754

29822

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.7

14.8

533

5342

S82

ICPC

Naevus/mole

0.8

14.7

1033

9341

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

14.6

689

3506

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

14.5

1241

6897

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

5.1

14.5

K91

ICPC

Cerebrovascular disease

1.8

14.5

245

989

F000, G300,

ICD-10 Finland

+∞

14.5

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

14.5

732

3769

SPAT1281

SPAT

Other administrative function

1.3

14.5

1014

5489

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.8

14.4

234

933

N06AX21

ATC

duloxetine; oral

1.3

14.4

1134

6235

SPAT1244

SPAT

Occupational therapy

2.0

14.4

160

563

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.9

14.4

3761

29822

GD1AD

NOMESCO Finland

Thorax CT examination

0.7

14.3

420

4375

115

Kela drug reimbursment

Breast cancer

0.7

14.3

592

5791

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

14.2

637

I95.9

ICD-10 Finland

Hypotension, unspecified

1.7

14.2

259

1069

M25.5

ICD-10 Finland

Pain in joint

0.8

14.2

2556

20890

R74

ICPC

Upper respiratory infection acute

0.8

14.1

1600

13678

SPAT1138

SPAT

Guidance concerning bowel function

1.7

14.1

247

1008

A11CC03

ATC

alfacalcidol; systemic

0.5

14.1

116

1691

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.6

14.1

321

3524

A23

ICPC

Risk factor NOS

1.4

14.1

672

3428

N07

ICPC

Convulsion/seizure

4.6

14.1

R45.1

ICD-10 Finland

Restlessness and agitation

3.8

14.0

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

14.0

2134

12652

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

14.0

1088

5973

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.7

14.0

381

4029

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.8

14.0

1324

11547

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.7

14.0

241

979

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

14.0

429

4430

A10AE05

ATC

insulin detemir; parenteral

1.4

14.0

682

3492

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

13.9

1836

10730

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

0.6

13.9

266

3038

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.2

13.9

1684

9756

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.5

13.8

165

2136

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

13.8

924

JN4BD

NOMESCO Finland

Extensive body CT

0.8

13.8

1095

9753

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.2

13.7

124

403

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

13.7

482

2325

F0001, G300,

ICD-10 Finland

+∞

13.6

HA1AA

NOMESCO Finland

X-ray mammography

0.7

13.6

490

4910

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.6

13.6

A05

ICPC

Feeling ill

1.5

13.6

502

2445

H04AA01

ATC

glucagon; nasal, parenteral

2.1

13.5

128

424

L02BG04

ATC

letrozole; oral

0.7

13.5

394

4109

S01

ICD-10 Finland

Open wound of head

1.9

13.4

175

652

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

13.4

4062

25518

R2110

NOMESCO Finland

Giving the first information

1.4

13.4

649

3319

OAB43, ,

SPAT

0.4

13.4

1322

A69.2

ICD-10 Finland

Lyme disease

0.6

13.4

316

3442

N02BF01

ATC

gabapentin; oral

0.7

13.4

525

5185

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.4

13.4

730

3807

U29

ICPC

Urinary symptom/complaint other

1.5

13.4

437

2077

GD1AA, ,

SPAT

0.6

13.4

272

3062

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

13.3

109

1592

S42.0

ICD-10 Finland

Fracture of clavicle

1.6

13.3

303

1326

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

13.3

196

2393

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

4.7

13.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

13.3

2423

14606

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.7

13.3

409

4218

P19

ICPC

Drug abuse

3.8

13.2

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.1

13.2

138

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

13.2

219

2590

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.6

13.2

233

2712

S18

ICPC

Laceration/cut

0.9

13.2

5947

45476

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

13.1

1170

ZXA05

NOMESCO Finland

Left side

1.2

13.1

4090

25747

R03BA08

ATC

ciclesonide; inhalant

0.7

13.1

500

4958

SPAT1042

SPAT

Guidance concerning balance maintenance

2.3

13.0

101

308

R40.2

ICD-10 Finland

Coma, unspecified

2.0

13.0

141

493

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

12.9

1245

10838

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.7

12.9

199

S06.3

ICD-10 Finland

Focal brain injury

1.8

12.9

184

707

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.4

12.9

1079

SPAT1127

SPAT

Enema

1.9

12.7

163

604

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

12.7

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

12.7

732

6803

XA400

NOMESCO Finland

EEG

2.5

12.7

234

C01DA14

ATC

isosorbide mononitrate; oral

1.2

12.6

3923

24673

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.0

12.6

135

HA1AA, ,

SPAT

0.3

12.5

889

A12AA04

ATC

calcium carbonate; oral

0.4

12.5

1036

AA1AA

NOMESCO Finland

Head X-ray examination

2.1

12.4

124

420

S20.2

ICD-10 Finland

Contusion of thorax

1.4

12.4

604

3092

P03

ICPC

Feeling depressed

1.4

12.4

530

2654

SPAT1081

SPAT

Cardiorespiratory global assessment

1.3

12.4

937

5128

WYA30, ,

SPAT

2.5

12.4

237

R31

ICD-10 Finland

Unspecified haematuria

1.2

12.3

1874

11103

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

12.3

429

2066

C10AA02

ATC

lovastatin; oral

1.3

12.3

829

4464

TK800

NOMESCO Finland

Hemodialysis

0.4

12.3

1208

ZXD35

NOMESCO Finland

Usual procedure

1.5

12.3

431

2079

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

12.3

1446

8349

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.2

12.2

103

326

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

2.8

12.1

165

R01AD12

ATC

fluticasone furoate; nasal

0.8

12.1

1876

15565

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

12.1

566

D07AA02

ATC

hydrocortisone; topical

1.2

12.1

1520

8838

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.7

12.0

216

889

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.4

12.0

530

2668

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

4.1

12.0

M02AA07

ATC

piroxicam; topical

1.1

12.0

5650

36512

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.5

12.0

115

1590

ZX120, ,

SPAT

2.0

12.0

134

474

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

11.9

800

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1.7

11.8

215

888

J01FA10

ATC

azithromycin; systemic

0.9

11.8

5170

39695

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

11.8

743

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.5

11.8

130

1721

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.8

11.7

738

6777

N06AX16

ATC

venlafaxine; oral

1.3

11.7

1048

5859

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

11.7

668

6219

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.4

11.7

1115

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.9

11.7

147

542

G40

ICD-10 Finland

Epilepsy

2.4

11.7

261

R18

ICD-10 Finland

Ascites

0.5

11.6

1288

N05AX12

ATC

aripiprazole; systemic

2.0

11.6

133

475

Z74.1

ICD-10 Finland

Need for assistance with personal care

6.7

11.6

SPAT1111

SPAT

Planning of analgesia

1.8

11.6

164

629

R01AD59

ATC

mometasone, combinations; nasal

0.4

11.6

874

F06.0

ICD-10 Finland

Organic hallucinosis

3.1

11.5

116

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

3.7

11.5

G04BD10

ATC

darifenacin; oral

2.1

11.5

119

410

SPAT1063

SPAT

Suctioning of mucus from airways

3.8

11.4

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

11.4

616

WX290

NOMESCO Finland

Other blockage of nerve

0.9

11.4

3015

23950

L03AA14

ATC

lipegfilgrastim; parenteral

0.3

11.4

792

L57.0

ICD-10 Finland

Actinic keratosis

0.8

11.4

1563

13116

G03DC02

ATC

norethisterone; oral

0.7

11.3

578

5469

R35

ICD-10 Finland

Polyuria

1.3

11.3

1028

5761

R4190

NOMESCO Finland

Nutritional therapy

0.5

11.3

1389

N05CD07

ATC

temazepam; oral

1.2

11.3

2235

13562

N05AH02

ATC

clozapine; systemic

2.5

11.2

218

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.6

11.2

141

1793

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.2

11.2

488

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.4

11.2

240

L01CB01

ATC

etoposide; systemic

0.1

11.2

301

N18

ICPC

Paralysis/weakness

1.6

11.2

300

1369

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.2

11.1

1323

7644

OAB41, ,

SPAT

2.3

11.1

267

C09CA06

ATC

candesartan; oral

0.9

11.1

2387

19272

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.9

11.1

3429

26950

SGA01

NOMESCO Finland

Emergency treatment

0.7

11.1

639

5939

L01CA04

ATC

vinorelbine; systemic

0.2

11.1

545

I50.1

ICD-10 Finland

Left ventricular failure

0.7

11.0

637

5920

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.2

11.0

555

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

5.5

11.0

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

0.7

11.0

338

3485

T82

ICPC

Obesity

0.4

11.0

1016

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

11.0

363

3692

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.3

11.0

679

F0009, G309,

ICD-10 Finland

+∞

10.9

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.6

10.8

184

K02.0

ICD-10 Finland

Caries limited to enamel

0.8

10.8

739

6711

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.1

10.8

3537

22294

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

10.8

1009

NF3AA

NOMESCO Finland

Femur X-ray examination

1.5

10.8

330

1550

S32.5

ICD-10 Finland

Fracture of pubis

1.8

10.7

166

656

A06

ICPC

Fainting/syncope

1.7

10.7

193

797

N05AB03

ATC

perphenazine; systemic, rectal

1.5

10.7

320

1496

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.4

10.7

1122

WX722

NOMESCO Finland

PEEP

0.7

10.6

311

3237

TGC00

NOMESCO Finland

Bronchial lavation

0.6

10.6

138

1739

250, ,

Kela drug reimbursment

0.4

10.6

952

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

10.6

292

1341

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

10.6

273

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

2.3

10.6

251

Z08

ICPC

Social welfare problem

2.0

10.5

122

438

P99

ICPC

Psychological disorders other

1.9

10.5

145

552

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

3.7

10.5

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.1

10.5

304

ZX080

NOMESCO Finland

Image guided radiotherapy

0.5

10.5

1172

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.7

10.4

559

5251

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.3

10.4

735

3986

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.5

10.4

1189

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.1

10.3

5163

33414

WX199

NOMESCO Finland

Other local analgesia

0.6

10.3

248

2686

HMAK, ,

NOMESCO Finland

0.8

10.3

676

6171

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.8

10.3

154

603

WX111

NOMESCO Finland

Local infiltration anesthesia

0.6

10.2

232

2544

Z11

ICPC

Compliance/being ill problem

2.1

10.2

314

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.7

10.2

272

2883

SPAT1255

SPAT

Intravenous administration of medicine

1.3

10.2

946

5314

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.4

10.2

853

N84.0

ICD-10 Finland

Polyp of corpus uteri

0.7

10.2

398

3928

L08

ICPC

Shoulder symptom/complaint

0.9

10.2

2081

16874

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.1

10.2

329

NG1AA, ,

SPAT

0.5

10.1

101

1376

F30.1

ICD-10 Finland

Mania without psychotic symptoms

5.2

10.1

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.6

10.0

174

2029

F0021, G301,

ICD-10 Finland

32.9

10.0

L76

ICPC

Fracture: other

1.4

10.0

435

2188

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.5

10.0

292

1359

R50.9

ICD-10 Finland

Fever, unspecified

1.2

10.0

1964

11905

F009, G308,

ICD-10 Finland

+∞

10.0

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.4

10.0

824

K90

ICPC

Stroke/cerebrovascular accident

1.4

9.9

505

2610

A07

ICPC

Coma

2.4

9.9

193

JN4CD

NOMESCO Finland

Very extensive body CT

0.7

9.9

282

2947

H91.1

ICD-10 Finland

Presbycusis

1.2

9.9

1437

8476

WZC30, ,

SPAT

0.7

9.9

347

3488

B81

ICPC

Anaemia vit B12/folate deficiency

1.3

9.8

634

3395

L01AX03

ATC

temozolomide; systemic

0.1

9.8

221

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.4

9.8

552

2897

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

9.8

391

1937

B01AA03

ATC

warfarin; systemic

1.1

9.8

4394

28243

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.7

9.7

365

3627

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

3.3

9.7

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.9

9.7

5163

39304

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

0.2

9.6

473

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

9.6

379

3735

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

0.7

9.6

410

3988

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

1.6

9.6

207

897

S01EX03, ,

ATC

1.4

9.6

439

2227

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.0

9.6

105

370

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.4

9.6

829

S01.7

ICD-10 Finland

Multiple open wounds of head

2.1

9.5

295

Z51.0

ICD-10 Finland

Radiotherapy session

0.4

9.5

849

R03BB01

ATC

ipratropium bromide; inhalant

0.7

9.5

499

4700

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.1

9.5

3434

21768

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.6

9.4

199

858

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

1.5

9.4

273

1270

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

1.8

9.4

130

497

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

3.5

9.4

R03AK08

ATC

formoterol and beclometasone; inhalant

0.6

9.4

213

2332

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

2.3

9.3

216

SGB30

NOMESCO Finland

Other complicated root filling

0.7

9.3

278

2880

128

Kela drug reimbursment

Cancers of female genital organs

0.5

9.3

987

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

9.2

104

371

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.6

9.2

141

1694

R4110, ,

SPAT

0.8

9.1

673

6051

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

9.1

928

5272

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.2

9.1

319

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.4

9.1

870

B01AC07

ATC

dipyridamole; systemic

1.2

9.1

1084

6269

F0001, G301,

ICD-10 Finland

+∞

9.1

S15

ICPC

Foreign body in skin

0.7

9.1

482

4528

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.5

9.0

290

1378

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.8

9.0

1038

8872

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

9.0

589

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.3

9.0

672

3673

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.4

9.0

866

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

9.0

251

1159

Q90.9

ICD-10 Finland

Down syndrome, unspecified

77.5

8.9

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

8.9

955

8223

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.4

8.9

743

S16

ICPC

Bruise/contusion

1.4

8.9

455

2355

F01

ICD-10 Finland

Vascular dementia

2.1

8.9

276

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

0.7

8.9

329

3273

UKC02

NOMESCO Finland

Cystoscopy

1.1

8.9

2978

18780

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

8.8

154

1791

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

0.4

8.8

899

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.9

8.8

1753

14254

L04AX03

ATC

methotrexate; systemic

0.8

8.8

632

5698

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.4

8.8

174

S72.2

ICD-10 Finland

Subtrochanteric fracture

1.7

8.7

151

618

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

2.4

8.7

179

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.6

8.7

140

1660

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

0.8

8.7

761

6697

J01FA09

ATC

clarithromycin; systemic

0.9

8.6

2634

20767

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

0.4

8.6

853

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.6

8.6

192

2110

L90

ICPC

Osteoarthrosis of knee

0.8

8.6

619

5580

K05.30

ICD-10 Finland

Periodontitis complex

0.8

8.6

1157

9736

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

8.6

627

G91.1

ICD-10 Finland

Obstructive hydrocephalus

2.6

8.6

142

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

0.2

8.6

262

EBA00

NOMESCO Finland

Extraction of tooth

1.1

8.6

3997

25713

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

0.3

8.6

605

G46.8

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

5.4

8.6

Z73.6

ICD-10 Finland

Limitation of activities due to disability

1.8

8.6

118

451

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.5

8.5

269

1274

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.8

8.5

534

4902

N43

ICPC

Neurological, Other diagnostic procedure

2.1

8.5

253

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.7

8.5

351

3428

SPAT1240

SPAT

Therapeutic discussion

1.3

8.5

654

3592

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

1.8

8.5

124

483

F32.0

ICD-10 Finland

Mild depressive episode

1.6

8.5

180

779

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.4

8.5

335

1659

SPAT1377

SPAT

Polysomnography

0.6

8.4

115

1424

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

0.7

8.4

437

4118

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.3

8.4

618

3374

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.9

8.4

2256

17943

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

0.9

8.4

4098

31402

T89

ICPC

Diabetes insulin dependent

1.5

8.4

277

1326

XX2RW, ,

NOMESCO Finland

0.3

8.3

487

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.7

8.3

393

3757

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.5

8.3

240

1117

B03XA02

ATC

darbepoetin alfa; parenteral

0.6

8.3

125

1507

WX723

NOMESCO Finland

CPAP therapy

0.6

8.3

114

1408

G04BX04, ,

ATC

1.5

8.3

298

1451

L02BG06

ATC

exemestane; oral

0.5

8.2

856

TFP34

NOMESCO Finland

Electrophysiological investigation

0.6

8.2

107

1342

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.5

8.2

1149

W18

ICD-10 Finland

Other fall on same level

2.0

8.2

343

SGC00

NOMESCO Finland

Medication, disinfection of root canals

0.7

8.2

446

4171

F0010, G308,

ICD-10 Finland

+∞

8.1

F0002, G300,

ICD-10 Finland

+∞

8.1

D10

ICPC

Vomiting

1.5

8.1

288

1397

H02.3

ICD-10 Finland

Blepharochalasis

0.8

8.1

588

5297

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.1

8.1

224

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

8.1

1335

11029

-1, ,

ICPC

1.4

8.1

440

2301

T68

ICD-10 Finland

Hypothermia

2.2

8.1

217

F0014, G309,

ICD-10 Finland

70.5

8.1

M03BX02

ATC

tizanidine; oral

0.9

8.1

5973

44817

R03DA04

ATC

theophylline; systemic, rectal

0.8

8.1

710

6244

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.2

8.0

204

R44.0

ICD-10 Finland

Auditory hallucinations

2.4

8.0

173

M76.6

ICD-10 Finland

Achilles tendinitis

0.7

8.0

218

2294

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

0.6

8.0

139

1615

C09AA05

ATC

ramipril; oral

1.1

8.0

4664

30363

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

7.9

5268

34519

B04AB02, ,

ATC

1.4

7.9

387

1989

L89

ICPC

Osteoarthrosis of hip

0.7

7.9

286

2856

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

0.3

7.9

537

R5120

NOMESCO Finland

Preparation of an aid

1.3

7.9

438

2299

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

7.9

448

RD211, ,

NOMESCO Finland

0.7

7.9

251

2562

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

0.6

7.8

176

1926

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.3

7.8

488

2607

G04BD04

ATC

oxybutynin; oral, transdermal

1.2

7.8

910

5254

A04AD12

ATC

aprepitant; systemic

0.4

7.8

758

SDA05

NOMESCO Finland

Very demanding periodontal treatment

0.7

7.8

247

2522

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

1.6

7.7

160

689

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

2.2

7.7

226

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

5.1

7.7

SPAT1064

SPAT

Management of tracheostomy stoma

3.3

7.7

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.5

7.7

804

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.1

7.7

250

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

0.7

7.7

215

2248

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

4.8

7.7

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.2

7.6

875

5039

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.7

7.6

327

3173

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

0.6

7.6

115

1385

R44

ICPC

Respiratory, Preventive immunization/medic

1.5

7.6

251

1201

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.3

7.6

578

3170

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.8

7.6

658

5798

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.8

7.6

1100

9193

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.5

7.6

1166

Angiography of the heart and coronary arteries

1.2

7.6

1341

8054

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.8

7.6

827

7102

N18.0

ICD-10 Finland

End-stage renal disease

0.5

7.6

789

S72.3

ICD-10 Finland

Fracture of shaft of femur

1.7

7.5

137

570

SPF30

NOMESCO Finland

Relining of denture

1.4

7.5

289

1425

D19

ICPC

Teeth/gum symptom/complaint

0.9

7.5

1978

15762

C08CA13

ATC

lercanidipine; oral

0.9

7.5

1890

15108

R4120, ,

SPAT

1.9

7.5

100

379

A57

ICPC

General and Unspecified, Physical medicine/rehabilitation

3.8

7.5

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

1.9

7.5

315

L04AX01

ATC

azathioprine; systemic

0.7

7.5

194

2060

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

0.7

7.4

214

2227

U08

ICPC

Urinary retention

1.4

7.4

316

1587

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.5

7.4

823

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.1

7.4

5108

33505

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.5

7.4

205

946

G03FB05

ATC

norethisterone and estrogen; systemic

0.8

7.4

864

7372

UJF30

NOMESCO Finland

Ileoscopy through colon

0.8

7.4

819

7026

U05

ICPC

Urination problems other

1.2

7.4

780

4452

E66

ICD-10 Finland

Obesity

0.6

7.4

106

1292

X59.0

ICD-10 Finland

Exposure to unspecified factor causing fracture

4.2

7.4

R03BB04

ATC

tiotropium bromide; inhalant

0.8

7.4

1358

11116

A01AB09

ATC

miconazole; local oral

1.2

7.4

1226

7324

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.2

7.4

928

5399

V613A

ICD-9 Finland

Other family circumstances, Problems with aged parents or in-laws

8.7

7.4

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

7.3

652

5727

P15

ICPC

Chronic alcohol abuse

1.6

7.3

154

666

B05DA

ATC

Isotonic solutions

0.2

7.3

278

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

0.7

7.3

405

3777

E66.00

ICD-10 Finland

Metabolic syndrome

0.7

7.3

276

2731

Z49.0

ICD-10 Finland

Preparatory care for dialysis

0.3

7.3

515

R12

ICD-10 Finland

Heartburn

0.8

7.3

522

4702

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.1

7.2

3341

21455

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

0.4

7.2

668

N03AF02

ATC

oxcarbazepine; oral

1.4

7.2

313

1578

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

1.9

7.2

319

A06AH03

ATC

naloxegol; oral

0.5

7.2

804

T11

ICPC

Dehydration

3.1

7.2

D06BB10

ATC

imiquimod; topical

0.8

7.2

435

4008

NG2AA

NOMESCO Finland

Patella X-ray examination

0.6

7.2

170

1839

WX780

NOMESCO Finland

Remote monitoring CPAP

0.6

7.2

134

1528

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.4

7.2

532

G03AC03

ATC

levonorgestrel; oral, implant

0.7

7.2

230

2343

SFA20

NOMESCO Finland

Two-surface restoration

0.9

7.2

5152

38772

R00.2

ICD-10 Finland

Palpitations

0.8

7.1

448

4107

SPA41

NOMESCO Finland

Precision impression for fixed dental prosthesis

0.3

7.1

456

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.1

7.1

215

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.3

7.1

484

2618

AA1ED

NOMESCO Finland

Trauma CT of head and neck

2.1

7.1

234

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

0.8

7.1

442

4056

D11

ICPC

Diarrhoea

1.2

7.1

999

5877

G03CA04

ATC

estriol; systemic, vaginal

1.2

7.1

1306

7871

D17

ICPC

Incontinence of bowel

1.7

7.1

141

602

TPH07

NOMESCO Finland

Cathetrisation of artery

0.8

7.1

1264

10373

JN6AD

NOMESCO Finland

CT of torso and neck

0.5

7.1

855

-31

ICPC

Medical examin/health eval partial

1.2

7.1

956

5603

H40.9

ICD-10 Finland

Glaucoma, unspecified

1.4

7.1

302

1520

F0020, G301,

ICD-10 Finland

19.4

7.0

K31

ICPC

Cardiovascular, Medical examin/health eval partial

1.8

7.0

103

403

R21

ICPC

Throat symptom/complaint

0.8

7.0

1065

8862

A02

ICPC

Chills

1.9

7.0

303

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

0.5

7.0

992

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

1.6

7.0

159

702

180

Kela drug reimbursment

Interferon alfa

0.2

7.0

232

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.9

7.0

3014

23292

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.1

7.0

4926

32335

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

7.0

461

L03

ICPC

Low back symptom/complaint

0.9

7.0

2652

20644

A02BC04

ATC

rabeprazole; oral

0.8

7.0

553

4920

TDA90, ,

SPAT

0.8

7.0

424

3902

Z60.2

ICD-10 Finland

Living alone

3.9

7.0

M05BA02

ATC

clodronic acid; systemic

0.3

7.0

394

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

0.3

6.9

405

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

0.1

6.9

166

K03.00

ICD-10 Finland

Approximal wear

0.7

6.9

288

2805

XKD00

NOMESCO Finland

Uroflowmetry

1.1

6.9

2864

18274

C10AA04

ATC

fluvastatin; oral

1.2

6.9

1617

9934

K29.4

ICD-10 Finland

Chronic atrophic gastritis

1.4

6.9

350

1813

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

0.9

6.9

2136

16838

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

0.5

6.9

912

F10.09

ICD-10 Finland

Alcohol intoxication UNS

1.7

6.9

130

548

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

0.8

6.9

771

6601

F38

ICPC

Eye, Other laboratory test NEC

0.5

6.8

892

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

0.1

6.8

183

IHZ07, ,

SPAT

2.3

6.8

155

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

1.7

6.8

121

501

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.6

6.8

1138

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

6.8

1270

7665

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.4

6.8

273

1360

TQW40

NOMESCO Finland

Remowal of suture of skin

0.8

6.8

496

4455

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

0.7

6.7

166

1779

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

0.8

6.7

718

6180

137

Kela drug reimbursment

Uraemia requiring dialysis

0.3

6.7

375

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.3

6.7

422

2258

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.2

6.7

748

4298

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

0.4

6.7

586

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.0

6.7

235

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

1.3

6.7

473

2574

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

2.0

6.7

240

L04AA06

ATC

mycophenolic acid; systemic

0.4

6.7

615

N81.6

ICD-10 Finland

Rectocele

0.8

6.7

494

4430

P01

ICPC

Feeling anxious/nervous/tense

1.3

6.7

472

2569

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.2

6.6

175

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

0.5

6.6

779

ZXC96

NOMESCO Finland

Robot assisted procedure

0.6

6.6

110

1289

A10AD05

ATC

insulin aspart; parenteral

1.4

6.6

327

1687

SPAT1243

SPAT

Psychiatric/psychological examination

1.8

6.6

380

AA1FD

NOMESCO Finland

Trauma CT of head and face

3.2

6.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

0.4

6.6

613

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

0.7

6.6

211

2149

L02BB04

ATC

enzalutamide; oral

0.5

6.6

720

AA1AG, ,

SPAT

4.6

6.6

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.4

6.6

349

1821

191

Kela drug reimbursment

Erlotinib

0.1

6.6

160

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.4

6.6

236

1151

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.7

6.6

192

1988

SPAT1109

SPAT

Analgesia with portable analgesic pump

1.8

6.6

371

WZA30

NOMESCO Finland

Assessment of driving capacity and statement

10.2

6.6

NK6AN

NOMESCO Finland

Total body bone isotope imaging

0.7

6.5

201

2062

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

0.6

6.5

121

1381

359

Kela drug reimbursment

Mirabegroni

1.8

6.5

356

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

1.6

6.5

133

572

H02BX01

ATC

methylprednisolone, combinations; systemic

1.2

6.5

808

4696

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

0.5

6.5

755

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

2.0

6.5

228

F0022, G301,

ICD-10 Finland

31.7

6.5

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

0.8

6.5

385

3555

ZXD05

NOMESCO Finland

Urgent procedure

1.1

6.5

4204

27464

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.3

6.5

373

1971

Z43.5

ICD-10 Finland

Attention to cystostomy

1.7

6.5

109

445

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

0.3

6.5

389

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

6.3

6.5

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.2

6.5

717

4118

R81

ICPC

Pneumonia

1.3

6.5

444

2406

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

0.8

6.5

585

5125

S51.0

ICD-10 Finland

Open wound of elbow

1.6

6.5

157

705

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

0.5

6.5

866

SPAT1277

SPAT

Instruction concerning legal protection and patient’s rights

2.9

6.5

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.1

6.5

4194

27401

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.8

6.5

597

5216

K80

ICPC

Cardiac arrhythmia NOS

0.8

6.4

769

6543

L02BA01

ATC

tamoxifen; oral

0.7

6.4

222

2230

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

7.5

6.4

XG474

NOMESCO Finland

Exhalation nntrogen oxide

0.6

6.4

993

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

1.7

6.4

115

478

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.2

6.4

743

4288

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

0.8

6.4

379

3500

LCA06

NOMESCO Finland

Biopsy of endometrium

0.8

6.4

579

5072

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.2

6.4

765

4430

A10BX01

ATC

guar gum; oral

1.2

6.4

659

3756

PJA10

NOMESCO Finland

Exploration of lymph nodes

0.5

6.4

672

IHA10, ,

SPAT

1.8

6.4

354

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

0.2

6.4

201

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

1.4

6.4

302

1549

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.0

6.3

240

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

0.6

6.3

145

1577

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

0.4

6.3

470

F0014, G308,

ICD-10 Finland

+∞

6.3

F0024, G309,

ICD-10 Finland

+∞

6.3

F0003, G300,

ICD-10 Finland

+∞

6.3

P69

ICPC

Psychological, Other reason for encounter NEC

4.4

6.3

R10.1

ICD-10 Finland

Pain localized to upper abdomen

0.9

6.3

1552

12432

A13

ICPC

Concern/fear medical treatment

1.4

6.3

227

1108

I42.0

ICD-10 Finland

Dilated cardiomyopathy

0.7

6.3

191

1964

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

0.5

6.3

746

R26

ICD-10 Finland

Abnormalities of gait and mobility

2.3

6.3

152

XW000

NOMESCO Finland

Bone marrow biopsy

0.7

6.3

346

3227

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

1.6

6.3

138

605

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

0.7

6.3

181

1879

B03XA01

ATC

erythropoietin; parenteral

0.4

6.3

620

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

0.4

6.3

530

Z10.0

ICD-10 Finland

Occupational health examination

0.4

6.3

519

ZXD20

NOMESCO Finland

Day surgery

1.2

6.3

1474

9061

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

0.8

6.2

511

4527

ACC51

NOMESCO Finland

Release of median nerve

0.8

6.2

473

4229

J01FF01

ATC

clindamycin; systemic

0.9

6.2

2839

21889

W10

ICD-10 Finland

Fall on and from stairs and steps

1.3

6.2

605

3425

NA3BG, ,

SPAT

0.6

6.2

1029

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.5

6.2

929

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

0.3

6.2

391

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

0.2

6.2

239

212

Kela drug reimbursment

Gout

0.7

6.2

187

1924

K78

ICPC

Atrial fibrillation/flutter

1.2

6.2

1533

9456

R41.2

ICD-10 Finland

Retrograde amnesia

3.2

6.2

ZYC01, ,

SPAT

1.2

6.2

727

4203

S01.2

ICD-10 Finland

Open wound of nose

1.5

6.2

167

769

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

6.2

1430

8779

A49

ICPC

General and Unspecified, Other preventive procedure

1.7

6.2

101

410

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

0.2

6.2

224

SXA20

NOMESCO Finland

Local application of medicine to mouth

0.7

6.1

206

2078

L13

ICPC

Hip symptom/complaint

0.9

6.1

2161

16908

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

0.8

6.1

921

7669

HA1AE, ,

SPAT

0.3

6.1

420

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

0.2

6.1

227

WVA40, ,

SPAT

2.0

6.1

224

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

0.7

6.1

188

1926

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.5

6.1

178

834

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

0.5

6.1

793

Z59.8

ICD-10 Finland

Other problems related to housing and economic circumstances

3.2

6.1

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

0.3

6.1

375

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

2.2

6.1

159

SPAT1325

SPAT

Vaccination

1.1

6.1

5790

38473

N05CF01

ATC

zopiclone; oral

1.1

6.1

5272

34891

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

1.6

6.1

123

529

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

0.2

6.1

236

SAD02, ,

SPAT

5.7

6.1

SPAT1097

SPAT

Recording of ECG

1.1

6.1

2293

14549

M76.0

ICD-10 Finland

Gluteal tendinitis

0.5

6.0

911

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.2

6.0

656

3762

S30.1

ICD-10 Finland

Contusion of abdominal wall

1.6

6.0

132

579

N30

ICD-10 Finland

Cystitis

1.2

6.0

830

4877

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.8

6.0

1083

8879

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5214

21908

1.96

308.98

2.8

3.1

2.45

2.47

mmol/l

19.85

4538

18818

(3021960) Folate [Moles/volume] in Serum or Plasma

6912

28509

2.16

307.65

1.7

1.6

20.63

20.36

nmol/l

0.57

6060

23681

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

903

420

15.89

307.65

1.0

54.71

35.69

ng/l

17.24

656

243

(3019309) Folate [Moles/volume] in Red Blood Cells

6928

25338

2.52

307.65

1.9

1.8

1182.98

1154.56

nmol/l

1.58

5156

18479

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

891

424

15.52

307.65

1.0

403.88

273.27

ng/l

15.60

654

252

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

902

420

15.88

307.65

1.0

569.20

771.48

ng/l

13.29

650

238

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9747

47739

1.97

307.65

2.4

2.1

91.45

93.13

pmol/l

2.64

5089

24333

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

831

1424

4.26

273.45

1.3

1.4

328.12

2521.68

e6/l

0.86

657

1192

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

830

1423

4.26

272.94

1.2

1.3

14.15

22.28

e6/l

0.52

636

1125

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

915

1695

3.95

272.42

1.2

1.3

509.67

574.66

mg/l

1.16

835

1614

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

827

1465

4.12

260.82

1.2

3.83

3.86

mmol/l

0.30

780

1364

(3015377) Calcium [Moles/volume] in Serum or Plasma

7499

36907

1.74

255.93

2.5

3.3

2.35

mmol/l

0.48

6392

31112

(3044290) Cell count panel - Cerebral spinal fluid

711

1345

3.84

205.10

1.1

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5219

24694

1.69

190.79

1.8

6694005.60

28797662.51

pmol/l

4.90

4213

19297

(3024561) Albumin [Mass/volume] in Serum or Plasma

8844

48246

1.58

178.30

3.6

4.5

34.68

34.10

g/l

17.86

7952

44071

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7494

39963

1.55

160.81

2.1

2.2

77.75

81.13

nmol/l

17.25

6378

34085

(3031040) Bacteria [#/volume] in Urine by Automated count

11683

68833

1.57

159.52

6.0

5.4

2953.75

1331.08

e6/l

2.06

328

1111

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

9180

51502

1.53

153.72

4.6

6.0

1.22

1.21

mmol/l

19.65

8197

46046

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9908

56930

1.51

144.07

5.1

6.7

1.22

1.21

mmol/l

34.76

8305

47524

(3023410) Appearance of Cerebral spinal fluid

379

581

4.67

141.88

1.2

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

486

921

3.79

139.49

3.3

3.9

322.43

331.38

umol/l

0.60

389

758

(3018418) pH of Serum or Plasma

6374

33642

1.52

136.50

3.0

4.1

7.40

1.26

930

6513

(3026008) Bacteria identified in Urine by Culture

7053

38656

1.47

121.43

3.8

3.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3037

13953

1.64

115.03

1.9

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4119

20422

1.55

112.98

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3033

14026

1.63

111.56

1.9

1.8

—

(3023368) Bacteria identified in Blood by Culture

6125

34102

1.40

88.15

3.9

4.4

—

(40768804) Tissue Pathology biopsy report

4256

39077

0.69

86.19

2.2

2.3

—

(3019150) Specific gravity of Urine by Refractometry

4102

21359

1.46

84.67

5.2

4.9

1.02

kg/l

0.44

654

3540

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6620

37938

1.36

76.90

2.4

2.1

—

(3016018) Differential panel - Cerebral spinal fluid

313

702

3.18

69.99

1.2

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12911

82584

1.37

68.62

5.0

2.04

2.11

mu/l

3.04

11522

72684

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10789

67501

1.32

63.61

3.8

4.1

15.22

15.24

pmol/l

0.37

9455

58989

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7461

44360

1.32

63.57

4.6

4.5

56.66

86.08

ng/l

1.67

5980

35648

(3003338) MCHC [Mass/volume]

10863

68133

1.32

62.10

26.4

26.0

330.11

330.36

g/l

2.12

10638

67336

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13894

90378

1.38

61.89

19.2

19.0

31.12

27.72

mg/l

20.53

11815

75319

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1569

7141

1.60

58.70

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

10950

69096

1.30

57.27

5.1

5.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5340

30716

1.32

55.38

2.3

2.4

3.00

3.18

mg/l

5.35

4371

25828

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5854

34190

1.31

54.03

2.2

2.1

261.02

216.66

u/l

2.93

5418

31626

(4035726) Immunohistochemistry procedure

790

9616

0.56

53.73

1.3

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1659

7929

1.52

49.68

1.8

1.7

—

(1761868) Lipid panel - Serum or Plasma

2292

21727

0.70

49.46

3.2

3.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1187

12767

0.63

48.83

1.2

14.84

16.61

u/ml

0.26

316

4117

(3020682) Albumin/Creatinine [Ratio] in Urine

4235

36196

0.77

44.52

3.3

3.8

9.83

9.97

mg/mmol

0.06

2622

22515

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

152

287

3.75

44.03

1.2

42.43

64.76

—

(3035350) Ketones [Presence] in Urine by Test strip

7799

48066

1.25

43.63

4.6

4.4

0.00

estimate

0.04

1302

10078

(3013826) Glucose [Moles/volume] in Serum or Plasma

9824

62197

1.25

43.12

4.5

4.8

7.05

6.91

mmol/l

6.57

9258

58589

(3017181) Myelocytes/100 leukocytes in Blood

787

9052

0.59

42.66

3.2

3.8

1.10

0.95

0.53

267

3430

(3002179) Metamyelocytes/100 leukocytes in Blood

686

8150

0.58

42.16

3.0

3.7

0.65

0.69

0.16

213

2924

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1339

13646

0.67

42.09

1.2

1.3

40.79

42.78

iu/ml

0.18

394

4157

(3021440) Promyelocytes/100 leukocytes in Blood

739

8591

0.59

41.74

3.3

3.8

0.14

0.10

0.81

223

2993

(3011397) Hemoglobin [Presence] in Urine by Test strip

4125

23668

1.30

40.95

4.5

4.2

—

(3012516) Albumin [Mass/volume] in Urine

3995

34091

0.77

40.47

2.9

3.2

483.73

395.53

mg/l

0.53

2578

21644

(3009508) Creatinine [Moles/volume] in Urine

4014

34228

0.77

40.41

2.8

3.1

6.87

6.74

mmol/l

1.22

3208

27677

(40761511) CBC panel - Blood by Automated count

13717

90598

1.29

40.29

18.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

14346

95328

1.31

40.13

23.5

23.0

139.70

139.46

mmol/l

17.94

13861

92637

(3023103) Potassium [Moles/volume] in Serum or Plasma

14353

95417

1.31

39.67

23.6

23.2

4.00

4.01

mmol/l

1.56

13841

92585

(3015736) pH of Urine

6365

38618

1.25

39.56

4.2

4.1

5.95

5.86

0.61

129

1005

(3009261) Glucose [Presence] in Urine by Test strip

7788

48584

1.23

36.42

4.6

4.4

0.00

estimate

1.34

1144

9027

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

719

8140

0.61

36.28

1.3

—

(3025159) Blasts/100 leukocytes in Blood

706

7990

0.61

35.55

3.2

3.8

0.32

0.39

0.12

192

2453

(3010813) Leukocytes [#/volume] in Blood

14412

96215

1.29

35.21

27.6

28.2

7.16

7.01

e9/l

5.26

13760

92459

(3009542) Hematocrit [Volume Fraction] of Blood

14403

96183

1.29

34.77

27.6

28.3

38.14

38.72

16.98

12586

87855

(3035941) MCH [Entitic mass]

14404

96203

1.29

34.62

27.5

28.1

30.42

0.19

13961

94092

(3026361) Erythrocytes [#/volume] in Blood

14404

96208

1.29

34.56

27.6

28.2

4.26

4.33

e12/l

47.17

13739

92416

(3007461) Platelets [#/volume] in Blood

14402

96196

1.29

34.52

27.6

28.2

235.51

238.05

e9/l

4.41

13816

92873

(3024731) MCV [Entitic volume]

14403

96206

1.29

34.49

27.5

28.1

91.98

91.95

0.28

13964

94096

(3000963) Hemoglobin [Mass/volume] in Blood

14404

96218

1.29

34.44

27.8

28.4

128.51

130.66

g/l

54.35

13944

94125

(3037522) Nuclear Ab [Titer] in Serum

1022

10576

0.66

34.20

1.2

1.3

485.66

528.14

titre

0.36

212

2517

(3029937) Albumin [Presence] in Urine by Test strip

4507

26677

1.25

33.45

5.1

4.8

0.00

estimate

1.34

1062

8643

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5926

36151

1.23

33.37

5.1

4.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

7657

47970

1.22

33.15

5.9

0.00

estimate

0.50

1146

9140

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

851

3834

1.59

32.74

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2703

23664

0.77

31.93

1.5

1.6

1.22

1.27

mmol/l

4.67

2331

19118

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3915

23030

1.25

30.10

4.3

203.15

440.06

ng/l

4.94

3544

20409

(3002256) Pathology report gross observation

1442

13648

0.72

29.02

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

197

3.48

25.54

1.2

29.00

23.68

—

(3019832) Treponema pallidum Ab [Presence] in Serum

415

1658

1.78

25.08

1.1

1.3

—

(40761535) Cells panel - Urine sediment

1781

9677

1.33

25.02

3.7

—

(3021589) Normoblasts [#/volume] in Blood

5208

41604

0.83

24.99

9.3

10.9

0.00

e9/l

1.32

4151

33750

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10961

82042

0.84

23.65

3.7

4.4

1.20

1.24

mmol/l

9.32

9399

71290

(3003694) ABO and Rh group [Type] in Blood

2575

21980

0.80

23.56

1.2

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3276

27233

0.81

23.41

2.4

3.0

7263.79

7007.89

umol/l

0.09

2619

22746

(3028026) IgM [Mass/volume] in Serum or Plasma

464

5239

0.61

22.93

1.9

1.89

1.42

g/l

1.14

376

4627

(3022145) Colonoscopy Study observation

1122

10649

0.72

22.63

1.2

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

8768

56844

1.17

21.81

20.1

21.2

1.39

1.42

inr

1.19

2007

15907

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1509

13602

0.76

21.28

2.9

3.8

16.89

23.40

ug/l

0.60

1225

11393

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1023

5228

1.40

21.11

1.5

1.63

1.65

0.34

841

4161

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

356

4203

0.59

21.11

2.6

4.0

176.74

89.41

u/ml

1.04

333

4023

(3018095) Leukocytes [#/volume] in Urine

6150

38892

1.17

20.45

4.1

162.90

130.78

e6/l

1.04

4454

28696

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11413

84755

0.85

20.08

4.2

4.9

1.46

1.45

mmol/l

1.11

9943

74545

(4200892) Spirometry reversibility

734

7336

0.69

20.05

1.4

—

(40768797) Stomach Pathology biopsy report

1567

13952

0.77

20.03

1.2

1.3

—

(4034850) Laboratory test

630

2973

1.51

19.75

13.4

13.3

—

(3000492) Spirometry study

682

6868

0.69

19.42

1.5

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11516

76690

1.16

18.61

5.6

7.8

80.42

82.54

u/l

3.21

10516

71512

(3005719) IgG [Mass/volume] in Serum or Plasma

652

6556

0.69

18.40

2.6

2.7

10.82

10.67

g/l

0.30

559

5938

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6053

46927

0.86

18.23

2.5

2.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1442

7942

1.30

18.17

5.1

6.4

24.48

24.58

mmol/l

0.40

1382

7551

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

160

517

2.19

17.83

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2037

11752

1.25

17.59

2.5

5.33

6.35

ug/l

2.33

1538

9917

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

788

7577

0.72

17.10

1.3

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

188

663

2.01

16.75

1.1

—

3.34

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

805

7673

0.73

16.53

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

183

646

2.00

16.28

2.4

2.3

—

(3002582) Erythrocytes [#/volume] in Urine

5457

34672

1.16

16.00

3.6

3.5

129.64

111.09

e6/l

0.26

4230

27085

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11629

85719

0.87

15.72

4.2

4.9

4.32

4.36

mmol/l

3.64

10212

76094

(3013707) Erythrocyte sedimentation rate by Westergren method

10614

70705

1.14

15.22

3.8

4.5

15.36

15.73

mm/h

1.34

9471

63879

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

251

2975

0.59

15.19

1.4

1.5

—

(36304419) Bacteria [Presence] in Urine

4778

30158

1.16

15.13

3.5

3.4

—

(3013512) EKG study

4340

34098

0.86

14.76

4.4

4.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

5849

44993

0.87

14.68

4.6

6.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

613

5982

0.71

14.55

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1570

8990

1.25

14.37

1.5

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

690

6585

0.73

14.26

1.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

216

2617

0.58

14.25

1.8

2.9

204.70

774.84

u/ml

2.64

190

2371

(3006270) Folate [Moles/volume] in Blood

256

1053

1.72

14.21

1.2

311.13

307.65

nmol/l

0.09

199

773

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

340

3692

0.64

14.18

1.5

1.6

37.09

38.28

u/l

0.39

266

3074

(40768793) Breast Pathology biopsy report

158

2075

0.53

13.89

1.2

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2997

18377

1.18

13.53

3.2

2.72

2.63

e6/l

0.17

1679

10442

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1775

14947

0.82

13.49

2.8

3.8

245.98

251.34

u/l

0.74

1577

13971

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

345

3692

0.65

13.45

1.5

1.6

156.00

235.46

titre

0.95

183

(3017143) Hepatitis C virus Ab [Presence] in Serum

669

6348

0.73

13.33

1.3

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

481

4817

0.69

13.29

1.4

1.5

44.32

18.52

u/ml

—

113

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

193

2356

0.57

13.13

1.6

1.7

12.55

12.43

mg/l

0.07

169

2123

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11474

84309

0.88

13.13

18.5

67.66

68.63

ml/min/173m2

5.75

9266

70290

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

572

2877

1.41

13.01

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2062

12282

1.21

12.87

3.2

3.1

240.97

273.68

ng/l

2.38

1885

11312

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

571

2877

1.41

12.87

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3183

19685

1.17

12.86

3.0

1.50

1.39

e6/l

0.30

1841

11673

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

876

0.32

12.79

1.5

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1579

13351

0.82

12.44

4.5

5.0

34.76

34.04

1.64

967

8496

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

121

1657

0.51

12.24

3.6

3.8

231.82

2222.09

iu/ml

1.17

244

(3007164) IgA [Mass/volume] in Serum or Plasma

1734

14505

0.82

12.23

1.4

1.5

2.75

2.72

g/l

0.11

775

7796

(3005322) IgE [Units/volume] in Serum or Plasma

384

3946

0.68

12.23

1.2

1.3

248.83

251.34

u/ml

0.03

336

3569

(3022621) pH of Urine by Test strip

1251

7124

1.25

11.99

3.7

3.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

278

3031

0.64

11.88

1.2

0.48

1.05

u/ml

1.51

306

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

291

3140

0.65

11.85

1.5

1.4

25.97

16.80

iu/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1381

0.48

11.76

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

178

2148

0.58

11.65

4.0

3.4

1.94

1.52

0.55

143

1852

(3042631) Mycobacterium sp identified in Specimen

161

1991

0.57

11.55

2.4

2.7

—

(3018572) Chloride [Moles/volume] in Blood

516

2614

1.40

11.32

4.3

6.1

104.83

104.81

mmol/l

0.02

474

2339

(3039000) Anion gap in Blood

516

2614

1.40

11.32

4.3

6.1

11.24

11.30

mmol/l

0.15

474

2339

(3000494) Fungus identified in Specimen by Culture

1280

10917

0.81

10.94

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

265

2.29

10.91

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5978

38944

1.12

10.80

2.6

3.0

140.29

161.53

ug/l

8.47

5196

34662

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

201

837

1.70

10.80

1.3

—

(3014271) Vancomycin [Susceptibility]

221

950

1.65

10.55

3.4

3.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

219

2444

0.63

10.45

1.2

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

6029

45635

0.89

10.42

4.9

6.1

8.94

8.96

0.19

5426

41905

(40768795) Lymph node Pathology biopsy report

1013

0.43

10.40

1.1

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

5996

45393

0.89

10.38

4.6

5.8

2.85

2.80

0.78

5390

41651

(3018010) Neutrophils/100 leukocytes in Blood

6009

45476

0.89

10.32

4.7

5.7

60.18

59.38

5.17

5419

41811

(3022096) Basophils/100 leukocytes in Blood

5822

44137

0.89

10.31

4.6

5.8

0.62

0.63

0.94

5222

40492

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

174

2044

0.60

10.31

1.2

3.39

4.89

u/ml

1.00

347

(40768443) Skin Pathology biopsy report

520

4927

0.74

10.30

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1329

11225

0.82

10.29

4.2

6.0

11.48

11.91

mmol/l

1.18

1212

10464

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

134

1674

0.56

10.04

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

173

2019

0.60

10.00

1.2

3.98

4.95

u/ml

0.18

227

(3002030) Lymphocytes/100 leukocytes in Blood

6132

46300

0.90

10.00

4.9

6.0

24.35

25.16

6.15

5525

42604

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

240

2.29

9.97

1.5

—

(4281824) Cell count and differential, peritoneal fluid

1068

0.46

9.83

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

687

3723

1.31

9.80

4.2

5.4

1.40

1.34

mmol/l

0.64

623

3308

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1286

0.51

9.80

1.4

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

233

2523

0.65

9.72

1.3

1.5

1.13

1.15

g/l

0.66

209

2367

(3042111) Morphology [Interpretation] in Bone marrow Narrative

198

2220

0.62

9.68

1.3

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

202

2249

0.63

9.58

2.3

2.1

204.84

212.76

0.64

183

2119

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

469

4457

0.73

9.50

2.3

3.0

153.13

2492.24

u/ml

2.97

368

3787

(3000850) Epithelial cells [#/volume] in Urine

3871

24738

1.13

9.40

2.8

2.7

5.42

5.06

e6/l

1.16

3466

22103

(21494755) Public health laboratory ask at order entry panel

893

0.42

9.39

1.3

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1010

0.46

9.37

1.0

1.1

1.60

1.57

g/l

0.28

885

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

179

2037

0.61

9.35

1.6

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

220

2386

0.64

9.27

1.9

89.89

87.35

1.06

208

2283

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

194

2159

0.63

9.20

1.2

42.96

40.46

u/ml

0.03

121

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

233

2490

0.65

9.16

1.5

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

501

4688

0.75

9.15

2.8

2.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

148

1752

0.59

9.10

1.2

1.89

6.66

u/ml

1.68

141

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2264

13989

1.16

9.01

9.8

8.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

230

2455

0.66

8.99

1.3

1.5

0.23

g/l

0.48

206

2292

(3020191) Ethanol [Moles/volume] in Serum or Plasma

116

434

1.89

8.97

1.2

0.78

1.03

promille

1.17

317

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

244

2571

0.66

8.95

1.9

2.1

3.64

3.67

g/l

0.10

224

2431

(3006315) Basophils [#/volume] in Blood

6418

48145

0.90

8.89

4.4

5.4

0.04

e9/l

1.10

5351

40551

(3013115) Eosinophils [#/volume] in Blood

6609

49504

0.90

8.88

4.6

5.6

0.20

e9/l

0.54

5550

42228

(3001604) Monocytes [#/volume] in Blood

6389

47933

0.90

8.86

4.4

5.4

0.63

0.64

e9/l

0.88

5322

40356

(4094501) Cardiovascular stress test using bicycle ergometer

212

2292

0.65

8.82

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

7528

56010

0.91

8.80

6.0

8.5

4.62

4.41

e9/l

7.94

6375

48178

(3030467) Casts [#/volume] in Urine by Automated count

4903

31877

1.11

8.74

3.5

3.4

0.56

0.51

e6/l

0.80

3815

24879

(3017354) Segmented neutrophils/100 leukocytes in Blood

103

1330

0.54

8.74

3.1

3.4

58.50

58.18

0.04

1084

(3023419) Bacteria identified in Sputum by Culture

172

1942

0.62

8.72

2.0

2.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

181

2009

0.63

8.52

1.1

158.57

144.44

titre

0.06

133

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

150

1729

0.61

8.32

1.6

1.8

16.59

24.08

ug/l

3.59

145

1683

(3044889) 12 lead EKG panel

9925

66958

1.10

8.25

4.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

149

619

1.70

8.20

1.2

2.12

2.31

mmol/l

0.94

137

562

(3044640) Blood type and Crossmatch panel - Blood

4454

33935

0.90

8.15

2.3

2.6

—

(3045142) Bone marrow Pathology biopsy report

105

1319

0.56

8.12

1.2

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

428

4019

0.74

8.05

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

178

1950

0.64

7.93

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

368

1.90

7.86

1.1

38.96

46.27

mg/l

1.11

316

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

955

8114

0.82

7.85

2.7

2.9

57.93

56.32

ml/min/173m2

0.78

402

3754

(3019198) Lymphocytes [#/volume] in Blood

6561

48944

0.91

7.73

4.6

5.5

1.76

1.87

e9/l

2.45

5547

42156

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

743

4198

1.26

7.71

1.9

2.2

965.57

543.22

ug/l

0.79

691

3961

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

303

1.98

7.63

3.0

2.7

26.92

29.61

umol/l

1.51

224

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

102

1265

0.57

7.57

1.6

2.0

574.33

1953.24

u/ml

—

(3002385) Erythrocyte distribution width [Ratio]

10929

74208

1.10

7.54

22.9

22.5

15.45

15.64

2.57

10667

72673

(3024980) IgG subclass 4 [Mass/volume] in Serum

1198

0.56

7.49

1.6

0.73

0.87

g/l

0.63

897

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3335

25709

0.89

7.46

2.2

2.5

—

(3011412) CD3 cells [#/volume] in Blood

783

0.46

7.41

2.5

1.8

0.97

1.05

e9/l

0.40

720

(3024891) Influenza virus A+B Ag [Presence] in Specimen

412

2167

1.35

7.33

1.2

—

(3008898) HLA-B27 [Presence]

107

1298

0.58

7.33

1.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1974

15685

0.87

7.18

3.4

5.1

1.03

1.04

mmol/l

1.83

1725

14229

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

304

1527

1.41

7.18

1.7

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5819

38482

1.10

7.05

4.9

5.9

6.07

4.87

ug/l

0.47

4974

33600

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12226

88522

0.91

7.05

4.9

5.6

2.44

2.48

mmol/l

6.02

10749

78327

(3004616) Nuclear Ab [Presence] in Serum

1137

0.56

6.98

1.1

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13687

94071

1.11

6.92

9.7

11.8

22.21

23.52

u/l

4.26

12850

89396

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

367

3426

0.75

6.70

1.5

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

252

2490

0.71

6.64

2.3

2.5

1.76

1.86

mg/l

1.02

202

2179

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

322

0.22

6.53

1.0

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2464

15634

1.13

6.52

2.0

2.3

1.73

1.78

1.69

2012

13568

(40768441) Liver Pathology biopsy report

587

0.42

6.46

1.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

142

1548

0.64

6.29

2.8

3.5

30.23

46.22

u/ml

1.62

134

1503

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1101

0.58

6.25

2.3

3.7

33.78

57.35

u/ml

2.49

1072

(3048689) Calprotectin [Mass/mass] in Stool

1052

8673

0.84

6.24

1.7

1.9

169.29

170.99

ug/g

0.04

765

6593

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.94

6.15

1.1

1.2

1.40

2.04

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4652

30615

1.09

6.09

4.6

5.1

22.06

22.53

1.31

2399

17145

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

344

1.80

6.09

1.0

1.1

278.04

325.68

mg/l

1.23

302

(3014765) Yersinia sp identified in Stool by Organism specific culture

482

2666

1.28

6.05

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

124

2.39

6.04

1.1

1.2

23.38

49.78

2.15

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1851

11592

1.14

6.02

4.8

6.6

120.06

118.84

g/l

1.87

1800

11268

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.25

5.98

1.1

1.3

46.23

42.09

0.12

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

741

0.50

5.97

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

766

4471

1.22

5.95

3.2

3.8

1.43

1.41

mmol/l

0.17

754

4378

(3024354) Oxygen [Partial pressure] in Venous blood

1595

9898

1.15

5.94

2.5

3.1

4.15

4.38

kpa

4.73

1516

9536

(42529406) Shigella sp [Presence] in Stool by Culture

482

2675

1.28

5.90

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

116

1302

0.62

5.89

1.4

1.3

0.12

0.32

nmol/l

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.52

5.88

1.1

1.3

13.42

13.71

0.02

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

105

1204

0.61

5.85

1.4

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1703

10630

1.14

5.83

4.0

5.7

1.48

1.38

mmol/l

3.51

1647

10273

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

761

0.52

5.79

3.1

3.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

475

2641

1.27

5.74

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

186

1883

0.69

5.70

2.3

3.1

4.87

4.49

e9/l

0.90

186

1877

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

191

1923

0.70

5.68

2.5

3.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

131

1419

0.65

5.68

1.2

65.69

44.68

u/ml

0.68

154

(3019060) Gas panel - Arterial blood

1403

8658

1.15

5.66

3.6

4.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

241

2329

0.72

5.61

1.4

1.5

30.79

31.26

g/l

0.25

213

2062

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

117

1294

0.63

5.59

1.4

1.3

0.68

0.83

nmol/l

0.57

107

1231

(3023183) Ammonium ion [Moles/volume] in Plasma

389

2120

1.30

5.51

1.5

2.1

26.15

32.96

umol/l

8.17

322

1809

(40757373) Influenza virus identified in Isolate

234

1.93

5.47

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

325

1.78

5.47

1.3

1.5

84.60

96.27

umol/l

0.28

193

(3003396) Base excess in Arterial blood by calculation

2263

14446

1.12

5.37

4.5

6.0

1.24

1.15

mmol/l

0.49

1710

11370

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

374

1.72

5.37

1.6

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

374

1.72

5.37

1.6

2.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

450

3970

0.79

5.36

1.1

74.40

126.56

iu/ml

2.97

143

1277

(21494814) CD8 cells/100 lymphocytes in Specimen

349

0.32

5.35

2.9

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

398

0.37

5.25

1.5

1.2

—

(3016502) Oxygen saturation in Arterial blood

2032

12912

1.12

5.23

4.6

6.2

95.17

95.15

0.03

1948

12371

(40765096) Chromosome analysis panel by Banding

344

0.33

5.21

1.3

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

732

0.54

5.15

1.1

1.2

2.80

3.72

u/ml

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7512

50684

1.08

5.09

2.8

3.1

49.60

57.55

u/l

9.77

6605

45137

(21494815) CD4 cells/100 lymphocytes in Specimen

607

0.50

5.06

2.1

1.7

37.93

37.09

0.17

590

(21494434) Karyotype in Bone marrow

102

1135

0.63

5.05

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

1048

0.62

5.05

1.1

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

154

1575

0.69

5.04

1.2

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

100

1117

0.63

5.04

1.3

113.81

124.91

u/ml

0.49

250

(3008116) Ketones [Moles/volume] in Urine by Test strip

187

2.00

5.03

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

254

2391

0.74

5.02

1.5

37.30

5.55

iu/ml

0.98

609

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

121

1296

0.65

5.02

1.3

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

642

3751

1.21

5.00

3.7

3.2

0.78

0.82

nmol/l

1.91

512

2909

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

507

0.46

4.96

1.6

1.3

1.11

1.48

u/ml

0.15

300

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

1627

0.69

4.95

1.2

1.4

—

(3042936) Bacteria identified in Isolate by Culture

2011

15606

0.90

4.92

1.9

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

132

1381

0.67

4.89

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4915

32674

1.08

4.88

2.2

2.5

76.19

61.18

u/l

0.44

4470

29825

(3040151) Glucose [Moles/volume] in Capillary blood

288

1534

1.33

4.87

7.9

12.8

7.84

7.32

mmol/l

1.42

230

1263

(40768800) Prostate Pathology biopsy report

275

2546

0.76

4.85

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

909

0.60

4.74

1.2

1.57

5.43

u/ml

3.50

291

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2385

18294

0.91

4.67

2.2

2.7

0.81

mmol/l

0.10

2109

16739

(3000012) Reticulocyte production index

234

2196

0.75

4.57

2.0

2.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

315

0.36

4.41

2.9

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

143

1442

0.70

4.39

1.4

1.5

73.02

63.30

3.00

900

(3036782) Glucose [Moles/volume] in Pleural fluid

148

1481

0.70

4.36

1.3

1.4

6.28

6.41

mmol/l

0.23

128

1377

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

566

0.52

4.34

2.3

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

247

0.28

4.31

3.3

2.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

781

0.59

4.30

1.1

114.95

114.98

0.00

667

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

345

1.66

4.28

2.6

2.0

62.44

52.70

umol/l

1.63

276

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

335

1.66

4.25

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

517

3009

1.22

4.25

1.2

—

(3011985) Renin [Units/volume] in Plasma

117

1215

0.68

4.23

1.1

1.4

44.08

58.58

mu/l

0.53

1063

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2238

14461

1.10

4.21

4.5

6.0

4.95

5.06

kpa

6.27

2115

13660

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

532

0.52

4.21

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

933

0.63

4.21

1.4

1.8

4.37

4.68

mg/l

0.35

876

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

513

0.51

4.20

1.3

1.1

0.29

0.83

u/ml

3.47

257

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

605

0.55

4.19

1.1

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2236

14451

1.10

4.19

4.5

6.0

11.45

11.72

kpa

1.67

2113

13642

(3008757) Leukocyte morphology finding [Identifier] in Blood

139

1395

0.70

4.18

4.6

3.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

888

7179

0.86

4.18

1.3

1.4

—

(40768806) Pleura Pathology biopsy report

184

1763

0.73

4.17

1.4

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

948

0.64

4.17

1.3

12.70

13.01

u/l

0.07

743

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

166

0.25

4.15

12.5

12.7

5.80

5.31

mmol/l

—

166

(3020891) Body temperature

816

4962

1.17

4.09

3.9

4.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

761

0.60

4.08

1.4

2.77

2.91

g/l

0.33

534

(3024139) IgG subclass 3 [Mass/volume] in Serum

761

0.60

4.08

1.4

0.44

0.45

g/l

0.09

533

(3027135) IgG subclass 1 [Mass/volume] in Serum

761

0.60

4.08

1.4

6.66

7.20

g/l

0.60

528

(3048929) Epstein Barr virus Ab [Presence] in Serum

131

1322

0.70

4.08

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

734

0.59

4.07

1.1

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

954

0.65

3.97

1.3

1.2

62.80

48.27

u/ml

—

(21494890) Protein electrophoresis panel - 24 hour Urine

150

1469

0.72

3.93

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

172

878

1.38

3.91

1.2

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

210

1952

0.75

3.90

1.3

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

854

0.63

3.87

1.2

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

854

0.63

3.87

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

169

862

1.38

3.86

1.2

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

877

0.64

3.82

1.2

4.60

4.50

u/ml

0.03

374

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

100

463

1.52

3.79

1.2

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

467

0.51

3.79

1.1

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

467

0.51

3.79

1.1

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

613

0.57

3.79

1.1

96.80

90.64

1.20

554

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

331

2896

0.80

3.79

1.8

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1028

0.67

3.78

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

594

4913

0.85

3.78

2.1

2.6

0.37

0.35

u/ml

0.90

332

2805

(3010726) Horse dander IgE Ab [Units/volume] in Serum

312

0.41

3.78

1.1

1.0

0.31

0.37

u/ml

0.14

168

(4062490) Immunoglobulin typing, IgG

762

0.62

3.77

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

603

0.57

3.77

1.1

1.6

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

575

0.56

3.74

2.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

111

1133

0.69

3.72

1.1

1.3

233.09

271.79

pmol/l

1.33

944

(3051387) C reactive protein [Mass/volume] in Capillary blood

432

2507

1.22

3.71

4.1

3.9

30.96

30.04

mg/l

0.18

316

1660

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

455

1.52

3.68

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2754

18074

1.09

3.67

1.7

1.9

29.68

30.21

4.01

2644

17529

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

267

0.37

3.67

2.6

2.1

—

(3012441) Differential panel - Pleural fluid

188

1757

0.75

3.66

1.4

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

105

1079

0.68

3.65

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

141

1376

0.72

3.65

3.2

3.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

389

3332

0.82

3.65

1.7

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

156

1.90

3.56

3.1

3.0

0.38

0.54

u/field

0.70

156

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

502

0.55

3.54

2.2

1.8

470.42

502.73

e6/l

0.17

430

(3014133) Dog dander IgE Ab [Units/volume] in Serum

252

0.36

3.54

1.1

1.0

0.04

1.92

u/ml

—

119

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

600

0.59

3.52

1.0

1.1

36.36

28.96

u/l

0.34

514

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

987

0.68

3.52

1.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

987

0.68

3.52

1.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

987

0.68

3.52

1.2

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

132

1293

0.72

3.51

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

599

0.59

3.50

1.0

1.1

99.65

88.30

u/l

0.44

517

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

164

1552

0.74

3.50

1.2

1.3

471.20

440.85

u/l

0.10

148

1463

(3041096) Erythrocytes [Presence] in Urine by Automated

3647

24244

1.07

3.48

4.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

195

1798

0.76

3.46

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

580

4769

0.85

3.46

2.5

3.1

56.64

81.58

mg/l

0.97

462

3864

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

442

0.52

3.43

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

124

1.99

3.40

2.0

2.2

155.85

129.42

nmol/l

0.75

106

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

112

1118

0.70

3.35

1.3

—

nmol/l

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

580

4755

0.85

3.35

2.5

3.1

46.71

51.14

mg/l

0.28

466

3852

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

484

0.55

3.35

1.0

291.37

291.24

mg/l

0.00

418

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

209

1129

1.31

3.34

1.6

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

465

0.54

3.33

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.52

3.32

1.2

1.1

12.83

17.00

nmol/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

115

1140

0.71

3.31

1.1

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

120

1181

0.71

3.31

1.1

1.2

61.33

61.75

u/l

0.02

100

1051

(3012565) Volume of 24 hour Urine

518

0.57

3.31

2.3

2.2

1654.48

1790.64

0.34

432

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

903

5624

1.14

3.30

2.4

3.7

24.13

mmol/l

0.01

863

5449

(3003888) Timothy IgE Ab [Units/volume] in Serum

436

0.53

3.30

1.1

1.0

1.01

1.74

u/ml

0.40

181

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

207

1.74

3.29

1.1

—

(3026782) Osmolality of Urine

3627

24155

1.07

3.28

3.1

3.2

553.13

534.18

mosm/kgh2o

6.68

3068

20639

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

471

0.55

3.27

1.2

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

159

0.31

3.26

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

192

1757

0.77

3.25

1.2

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

423

0.53

3.22

1.1

1.0

0.44

0.97

u/ml

0.66

166

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

3.21

0.0

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

486

0.56

3.20

1.5

5.34

6.21

u/l

0.91

390

(3028707) Methadone [Presence] in Urine by Screen method

137

1.90

3.20

1.1

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

557

0.59

3.19

1.3

1.4

3.09

2.52

0.21

464

(3028717) Thiamine [Mass/volume] in Blood

2.25

3.18

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

227

2025

0.79

3.15

1.4

1.5

3642.87

2232.37

e6/l

0.62

166

1461

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

834

6631

0.88

3.15

5.6

7.3

24.20

24.38

mmol/l

0.81

776

6301

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

588

0.61

3.11

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

709

0.64

3.11

1.1

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

256

0.41

3.10

1.1

1.4

121.18

147.26

pmol/l

0.40

256

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

219

1957

0.79

3.09

1.3

39.23

41.47

u/l

0.11

189

1674

(3016750) Collection duration of Urine

716

0.65

3.08

2.2

2.0

492.02

499.28

min

0.20

499

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

180

1648

0.77

3.08

1.2

1.3

0.82

0.81

nmol/l

0.01

142

1341

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

809

0.67

3.08

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

453

0.56

3.07

2.0

2.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1470

9456

1.10

3.07

2.7

3.6

87.75

99.44

ng/l

6.23

1180

7787

(3022313) Gas panel - Capillary blood

703

5641

0.87

3.06

3.1

3.9

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

341

0.49

3.04

1.7

1.5

8.79

9.79

ug/l

0.22

305

(3020630) Protein [Mass/volume] in Serum or Plasma

1479

11367

0.91

3.03

2.1

2.5

65.53

65.81

g/l

0.68

1225

10069

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

225

1999

0.79

3.03

1.3

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

154

1436

0.75

3.02

1.2

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

100

997

0.70

3.02

1.1

1.2

254.03

290.89

u/ml

0.74

587

(3004775) Volume in Urine collected for unspecified duration

105

1038

0.71

3.01

2.2

609.29

649.23

0.46

656

(3021162) Amylase [Enzymatic activity/volume] in Specimen

163

0.35

2.99

2.0

2.6

906.75

1278.68

u/l

—

153

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

118

1142

0.73

2.98

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

537

0.60

2.97

1.2

1.4

3.36

3.56

0.07

122

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

455

1.46

2.96

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

569

4622

0.86

2.96

2.6

3.1

3.07

5.36

ratio

0.67

324

(3003181) Sodium [Moles/volume] in Urine

406

2401

1.19

2.95

1.3

63.99

60.89

mmol/l

0.94

331

1934

(1761482) Bacteria [#/volume] in Urine by Culture

482

3964

0.85

2.94

5.0

4.9

—

(3013637) Mi-2 Ab [Presence] in Serum

240

0.41

2.94

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

240

0.41

2.94

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

240

0.41

2.94

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

240

0.41

2.94

1.2

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

638

0.64

2.91

1.2

1.4

61.12

66.86

0.55

515

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

189

1704

0.78

2.89

1.2

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

174

1583

0.77

2.87

1.4

—

(3021788) Differential panel - Synovial fluid

235

2061

0.80

2.85

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

379

0.54

2.85

2.9

2.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

719

0.66

2.84

1.2

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

132

1245

0.74

2.83

1.2

1.3

24.51

12.08

u/l

1.94

115

1137

(3024522) Salmonella sp identified in Specimen by Organism specific culture

158

1453

0.76

2.83

1.2

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

104

1017

0.72

2.82

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

718

0.67

2.82

1.2

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

467

2809

1.18

2.81

2.8

2.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

749

0.68

2.77

1.3

1.2

8.07

8.02

mmol/l

0.04

577

(3028308) Erythrocytes [#/volume] in Pleural fluid

209

1850

0.79

2.76

1.4

1.5

55020.84

68793.19

e6/l

0.35

127

1095

(3008037) Lactate [Moles/volume] in Venous blood

410

3396

0.85

2.76

3.4

3.6

1.75

1.64

mmol/l

1.27

398

3329

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

365

0.54

2.74

1.2

—

(1002224) Polysomnography panel

157

1438

0.77

2.74

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

539

0.63

2.67

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

538

0.63

2.65

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

538

0.63

2.65

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

674

0.67

2.64

1.3

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

114

1085

0.74

2.63

1.4

1.5

16.27

26.74

5.72

676

(3025468) Yersinia sp identified in Specimen by Organism specific culture

157

1428

0.77

2.62

1.2

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

440

0.59

2.62

2.5

43.05

36.27

1.46

275

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

350

0.54

2.61

1.7

4623.08

16054.84

e6/l

1.08

196

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

294

0.50

2.60

1.2

1.3

56.50

36.87

u/l

0.92

236

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

535

0.63

2.60

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

535

0.63

2.60

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

534

0.63

2.58

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

153

1390

0.77

2.54

1.4

1.6

2.85

3.49

mg/l

0.38

115

1063

(3005988) Vibrio sp identified in Specimen by Organism specific culture

158

1429

0.78

2.53

1.2

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

372

3081

0.85

2.53

2.3

2.9

7.43

7.75

kpa

3.28

366

3004

(3023487) Leukocytes [#/volume] in Peritoneal fluid

391

0.58

2.52

1.7

1.8

528.11

4557.32

e6/l

1.03

266

(3000093) Morphology [Interpretation] in Blood Narrative

136

1253

0.76

2.52

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

394

3245

0.85

2.51

3.5

3.7

8.26

7.69

mmol/l

2.68

384

3182

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

158

1425

0.78

2.48

1.2

1.4

—

(3025130) Human papilloma virus identified in Specimen

459

0.61

2.47

2.0

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

406

0.59

2.46

1.8

956.74

1731.96

u/ml

1.90

392

(40758358) Immune stain study

0.00

2.46

0.0

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

688

0.68

2.46

1.1

1.2

287.50

117.44

titre

0.62

129

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

295

1728

1.21

2.44

1.1

10.12

14.07

u/ml

—

(3034426) Prothrombin time (PT)

201

0.42

2.44

1.1

1.2

—

(3002032) Base excess in Venous blood by calculation

1825

11984

1.08

2.43

2.7

3.6

2.01

1.95

mmol/l

0.28

1534

10049

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

165

1475

0.79

2.42

1.2

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

163

1459

0.78

2.42

1.9

2.4

0.76

1.12

g/24h

1.18

687

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

942

6004

1.11

2.42

2.2

2.5

1.15

1.13

0.43

935

5973

(3039443) Prostate specific Ag panel - Serum or Plasma

834

0.72

2.41

1.5

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

184

1623

0.80

2.41

1.6

1.7

4.37

4.38

mmol/24h

0.00

139

1341

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1409

9164

1.09

2.38

2.1

2.4

35.59

41.51

u/l

0.66

1148

7740

(3044242) Glucose [Moles/volume] in Arterial blood

121

639

1.34

2.38

1.9

1.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

146

0.39

2.34

1.1

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

656

0.69

2.34

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

656

0.69

2.34

1.4

1.5

—

(40761536) Microorganisms panel - Urine sediment

1126

8647

0.91

2.33

4.8

4.6

—

(4146454) Self-monitoring of blood glucose

157

1403

0.79

2.32

2.5

2.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

439

3560

0.86

2.31

2.7

3.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

2.31

0.0

12.0

—

220.43

—

(1616796) Gas panel - Central venous blood

361

2969

0.85

2.29

3.1

3.7

—

(3035880) pH of Pleural fluid

923

0.74

2.29

1.1

1.3

—

(3047189) Immunofixation for 24 hour Urine

642

0.69

2.25

1.2

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1823

12014

1.08

2.23

2.7

3.6

5.84

5.83

kpa

0.20

1746

11629

(3017569) Oxygen content in Arterial blood

672

0.70

2.20

2.7

2.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

695

0.71

2.17

1.6

1.5

4.02

7.55

u/l

1.45

549

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

109

1009

0.76

2.14

1.1

72.53

491.03

iu/ml

0.80

172

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

319

0.57

2.13

1.1

1.05

1.11

ratio

—

(3009343) pH of Capillary blood

1034

7934

0.91

2.12

2.9

3.8

7.42

0.66

135

1053

(3028433) Virus identified in Specimen by Culture

345

0.59

2.12

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

838

5352

1.11

2.11

3.8

4.6

0.92

0.86

4.34

793

5032

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1048

8032

0.91

2.10

2.9

3.8

5.16

kpa

0.02

942

7543

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

139

0.40

2.09

1.5

1.7

—

(44813793) Dust mix specific IgE antibody measurement

422

0.63

2.09

1.0

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

919

5901

1.10

2.08

2.2

2.5

0.68

0.66

1.12

913

5874

(3024932) HLA-DR beta [Type]

127

0.39

2.08

1.3

1.1

—

(3045788) Cell count panel - Pleural fluid

177

1536

0.81

2.05

1.4

1.5

—

(3022689) Creatine [Moles/volume] in Urine

279

0.55

2.05

1.3

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

182

1.59

2.02

1.2

1.3

—

(3008295) Osmolality of Serum or Plasma

193

1108

1.23

2.02

1.3

274.74

274.79

mosm/kgh2o

0.01

137

804

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

845

5414

1.10

2.01

3.8

4.6

1.68

1.55

1.84

799

5101

(3008536) Aspergillus sp Ab [Presence] in Serum

194

0.47

2.01

1.6

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1000

7661

0.91

2.00

2.9

3.7

1.84

2.06

mmol/l

1.11

708

5673

(3017446) Testosterone [Moles/volume] in Serum or Plasma

662

5176

0.90

2.00

2.0

10.36

10.57

nmol/l

0.23

538

4309

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

125

1124

0.78

1.99

1.3

1.4

13.97

13.49

u/l

0.39

115

1073

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

310

2545

0.86

1.97

1.3

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

328

2681

0.86

1.97

1.3

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

202

0.49

1.97

1.1

1.3

113.50

115.06

—

174

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

949

6123

1.10

1.96

3.5

4.3

46.04

46.16

0.05

934

6053

(40768446) Kidney Pathology biopsy report

239

0.53

1.96

1.1

1.5

—

(3012544) pH of Venous blood

1872

12416

1.07

1.94

2.7

3.6

7.39

—

(3036489) Thrombin time

407

3269

0.87

1.93

1.6

1.8

21.83

22.16

0.24

366

2963

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

838

5382

1.10

1.92

1.9

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

896

0.76

1.92

1.6

1.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

277

1.45

1.89

1.4

1.5

17.56

17.02

pmol/l

0.25

218

(3004451) EKG impression Narrative

724

0.74

1.87

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

383

3080

0.87

1.86

1.3

1.4

—

(3045414) Leukocytes [Presence] in Urine

695

4432

1.11

1.84

2.2

2.0

—

(3024471) HLA-A [Type]

133

0.42

1.84

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

777

4984

1.10

1.84

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

187

0.49

1.83

4.0

7.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

194

1128

1.21

1.83

1.8

1.6

30.55

25.67

u/ml

0.71

235

(3019225) pH of Specimen

1838

12209

1.07

1.83

4.0

4.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

338

0.62

1.80

1.1

1.2

130.50

154.63

mmol/24h

0.83

338

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

157

0.45

1.80

1.0

1.4

—

10.83

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2306

17060

0.94

1.78

2.1

2.6

20.38

20.86

0.85

1714

14334

(3011288) Drugs identified in Urine by Screen method

144

1.61

1.77

1.4

1.9

—

(3036048) Francisella tularensis Ab [Titer] in Serum

165

0.47

1.76

1.2

—

1874.29

—

(3026470) Cobalt [Mass/volume] in Blood

100

906

0.78

1.74

1.8

1.9

2.29

4.26

ug/l

3.79

824

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

193

1627

0.83

1.73

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

253

2084

0.85

1.72

2.6

2.5

106.25

105.54

mmol/l

1.22

248

2066

(3041354) Potassium [Moles/volume] in Venous blood

253

2084

0.85

1.72

2.6

2.5

4.16

4.11

mmol/l

0.95

248

2067

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

273

0.59

1.72

1.3

1.4

15.14

9.77

—

139

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

351

0.64

1.72

1.1

1.7

93.26

96.82

0.30

331

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.83

1.72

1.0

—

(40758558) Short blood count panel - Blood

3609

24477

1.05

1.70

5.0

6.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

251

2062

0.85

1.67

2.6

2.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

432

0.68

1.66

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

122

1072

0.80

1.66

1.1

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.83

1.66

1.1

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1266

9522

0.93

1.65

2.1

2.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2830

20778

0.95

1.65

1.6

1.7

1.71

1.57

mg/l

0.90

2167

16379

(3010370) Gastrin [Moles/volume] in Serum or Plasma

136

0.47

1.65

3.1

1.4

74.67

62.62

pmol/l

—

104

(3007147) Virus identified in Stool by Electron microscopy

3.91

1.65

1.0

—

(3021901) Oxygen saturation in Capillary blood

330

2651

0.87

1.62

2.4

2.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

120

1053

0.80

1.62

1.1

—

(3016038) Potassium [Moles/volume] in Urine

151

869

1.23

1.61

1.1

36.48

35.04

mmol/l

0.30

115

722

(3043410) Blood group antigens tested for on Red Blood Cells

336

0.65

1.60

1.8

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

160

1.54

1.58

2.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

875

6663

0.92

1.58

1.5

1.6

1.62

1.57

g/l

0.79

692

5643

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

114

0.43

1.58

1.3

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

116

1018

0.80

1.57

1.1

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

343

0.66

1.57

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

212

0.56

1.56

3.9

2.6

—

(3020393) Adenovirus Ag [Presence] in Stool

100

1.69

1.55

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

314

1.37

1.52

1.1

18.82

547.36

ng/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

228

0.59

1.52

4.8

7.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

673

0.76

1.50

2.3

2.2

28.84

135.11

ug/min

2.10

157

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

712

0.77

1.49

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

222

1.43

1.44

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

605

0.76

1.44

4.7

3.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

405

3180

0.89

1.41

1.3

1.4

256.63

259.75

ug/g

0.12

219

1979

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

613

4711

0.91

1.40

3.3

4.3

24.98

24.91

mmol/l

0.22

522

4252

(3020911) Cortisol [Moles/time] in 24 hour Urine

240

0.62

1.40

1.3

1.4

75.24

180.95

nmol/24h

1.27

240

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

650

0.77

1.40

1.0

1.1

3.99

4.19

u/ml

0.04

124

(3036670) Protein [Mass/volume] in Synovial fluid

424

0.71

1.39

1.1

1.2

39.19

40.09

g/l

0.22

206

(3045424) Erythrocytes [Presence] in Urine

204

1674

0.86

1.39

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

201

1650

0.86

1.38

1.3

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

201

1650

0.86

1.38

1.3

1.4

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

1.38

0.0

1.1

—

15.74

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

195

0.58

1.38

1.5

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

672

0.77

1.38

1.1

1.2

87.58

95.06

u/l

0.27

582

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

161

1.49

1.35

2.2

2.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

280

0.65

1.35

1.3

1.4

12.86

15.52

g/l

0.78

219

(3027035) Albumin [Mass/time] in 24 hour Urine

107

0.46

1.34

1.6

1.2

—

876.22

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

1.34

0.0

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

923

6959

0.93

1.34

2.5

2.6

—

(3002619) Bacteria identified in Specimen by Culture

214

1.42

1.34

1.3

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

420

0.72

1.33

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

270

0.65

1.32

5.0

5.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.01

1.31

1.3

1.1

—

(3017732) Neutrophils [#/volume] in Blood

825

6239

0.93

1.30

3.3

6.23

5.69

e9/l

0.26

572

4441

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

437

3398

0.90

1.30

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

191

0.59

1.29

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

146

0.53

1.28

1.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

668

5089

0.92

1.28

1.8

2.3

10.44

10.24

g/l

0.48

529

4365

(3036180) Methadone [Presence] in Urine

1.79

1.28

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.41

1.27

1.2

1.4

—

(3048879) Bone marrow aspiration report

440

0.74

1.26

1.2

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

207

0.61

1.26

1.1

1.4

1.56

1.54

g/l

0.10

207

(3011648) Oxygen content in Venous blood

764

0.80

1.25

1.2

1.6

10.34

10.49

0.12

764

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

278

1.34

1.23

1.1

1.06

1.11

u/l

0.39

139

(3026726) Creatinine [Moles/volume] in Specimen

103

0.48

1.23

2.7

2.4

173.29

414.42

umol/l

—

(3025577) Chromium [Mass/volume] in Blood

101

870

0.82

1.22

1.9

2.0

1.60

2.39

ug/l

3.11

720

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

120

0.53

1.21

1.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

452

3493

0.91

1.21

2.4

3.1

24.78

25.01

mmol/l

0.65

440

3420

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.64

1.20

10.3

11.3

—

(3016879) Cocaine [Presence] in Urine

213

1.39

1.20

1.2

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

272

0.67

1.20

1.3

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.71

1.20

3.2

9.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

195

0.61

1.19

1.2

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

1.19

0.0

1.0

—

0.01

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

1.19

0.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

220

1.38

1.17

1.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2240

16387

0.96

1.16

1.2

1.72

1.75

u/ml

0.03

477

3799

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

457

0.75

1.16

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.44

1.15

1.2

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

239

1.36

1.15

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

770

0.81

1.14

1.8

166.25

186.36

pmol/l

1.71

695

(3033799) Differential panel - Peritoneal fluid

343

0.72

1.14

1.7

—

(3027315) Oxygen [Partial pressure] in Blood

377

2928

0.90

1.13

3.6

4.4

8.01

8.30

kpa

2.19

363

2845

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

159

1304

0.86

1.13

1.3

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

113

660

1.21

1.13

1.3

1.5

—

3.00

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

716

5407

0.93

1.13

1.9

2.3

3.79

3.70

g/l

0.71

579

4732

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

198

1597

0.87

1.13

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

240

1.35

1.13

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

457

1.25

1.12

1.2

1.3

1.01

1.16

nmol/l

0.83

342

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.50

1.12

6.6

4.5

26.43

54.60

ug/min

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

194

1565

0.87

1.11

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

477

0.77

1.10

5.6

5.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

735

0.81

1.10

1.3

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

138

0.56

1.09

1.1

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

218

1742

0.88

1.09

2.2

33.61

27.82

mg/l

0.63

426

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

242

1.34

1.08

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

347

0.73

1.07

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

146

0.58

1.07

4.3

7.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

126

1047

0.85

1.07

1.3

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

198

1590

0.88

1.07

5.0

5.9

12.94

12.52

mg/l

0.61

170

1423

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

719

5416

0.93

1.07

1.8

2.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

387

0.75

1.07

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

387

0.75

1.07

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

381

2946

0.91

1.07

2.0

2.2

114.75

105.03

ug/min

0.14

208

1645

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

720

5421

0.93

1.06

1.9

2.3

7.65

7.54

g/l

0.95

581

4744

(3027008) Opiates [Presence] in Urine

225

1.35

1.05

1.2

1.3

—

(3019977) pH of Arterial blood

129

770

1.18

1.04

2.1

2.3

7.43

7.42

0.27

309

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

111

654

1.20

1.04

2.3

2.1

2.03

2.33

u/field

0.22

429

(3003327) Ova and parasites identified in Stool by Light microscopy

296

2314

0.90

1.03

1.5

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

287

0.71

1.03

1.1

1.2

1.54

1.50

mmol/l

0.06

176

(3028300) Cannabinoids [Presence] in Urine

226

1.34

1.02

1.2

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1163

7778

1.06

1.02

2.6

3.3

127.68

125.55

g/l

2.85

1133

7586

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

166

1.40

1.02

1.2

1.3

81.40

108.43

ug/l

0.67

105

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

650

0.81

1.01

1.1

1.2

29.24

28.89

u/l

0.02

555

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

187

1153

1.14

1.00

2.5

2.3

2.34

2.30

u/field

0.03

378

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

1.00

0.0

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

485

0.78

1.00

1.4

49.68

35.82

iu/l

1.58

406

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

295

1.29

0.99

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

277

0.71

0.99

1.5

1.3

28.77

30.53

umol/l

0.57

264

(3013290) Carbon dioxide [Partial pressure] in Blood

378

2911

0.91

0.99

3.6

4.4

4.99

5.01

kpa

0.14

365

2828

(3024263) Appearance of Synovial fluid

568

1.20

0.98

1.2

1.3

—

(3037121) Protein [Mass/volume] in Urine

539

4087

0.93

0.98

2.4

2.8

0.29

0.31

g/l

0.37

179

1599

(3012501) Base excess in Blood by calculation

378

2909

0.91

0.98

3.6

4.4

2.47

2.80

mmol/l

1.32

258

2009

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

498

1.22

0.97

1.1

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

201

0.67

0.97

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

127

1043

0.86

0.96

2.7

3.1

32.74

38.12

mg/l

0.20

772

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

272

1.29

0.96

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

622

0.81

0.95

4.4

4.8

61.57

133.71

u/ml

0.67

179

(3044007) Cell count panel - Peritoneal fluid

307

0.73

0.95

1.8

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.49

0.91

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

173

0.65

0.91

2.6

2.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.48

0.91

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

525

0.80

0.91

1.0

1.1

1.38

9.98

nmol/l

2.09

120

(3030981) Hyaline casts [#/volume] in Urine by Automated count

971

6489

1.06

0.91

3.2

2.9

0.44

0.30

e6/l

1.19

954

6379

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

109

0.58

0.90

1.2

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

255

0.72

0.90

1.2

1.3

—

(40762814) Titanium [Mass/volume] in Blood

255

0.72

0.90

2.2

2.1

2.89

3.49

ug/l

0.93

(3006462) Nitrate [Presence] in Urine

555

0.81

0.89

4.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

375

0.77

0.89

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

238

1.30

0.89

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

655

0.83

0.89

1.1

1.2

249.67

181.87

miu/ml

0.35

129

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

343

0.76

0.89

1.5

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

437

0.79

0.88

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

208

1.32

0.88

1.0

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1190

8009

1.05

0.86

1.7

2.1

398.69

385.22

nmol/l

1.38

1024

7202

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

797

0.85

0.86

1.1

—

(3027944) Amphetamines [Presence] in Urine

215

1.31

0.86

1.2

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

268

0.74

0.85

1.3

1.4

0.13

0.12

nmol/l

0.05

190

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

151

932

1.14

0.84

1.3

277.62

362.40

titre

0.28

(3006184) Hemoglobin [Mass/volume] in Capillary blood

459

3003

1.08

0.84

2.1

2.3

126.98

125.41

g/l

0.64

360

2184

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

194

0.69

0.83

1.3

—

2393057.14

—

(40762887) Creatinine [Moles/volume] in Blood

1.92

0.82

1.2

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

274

0.74

0.81

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

201

0.70

0.81

1.6

1.7

9.81

9.88

ug/l

0.03

201

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.81

0.0

1.1

—

8.26

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.81

0.0

8.9

—

39.83

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.80

0.0

1.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5928

41067

1.02

0.80

3.0

3.3

2164.80

1989.19

ng/l

1.64

5022

35897

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.79

0.0

7.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

272

0.75

0.78

1.2

1.3

2.63

940.45

u/l

—

(3000475) Leukocytes [#/volume] in Synovial fluid

360

2739

0.92

0.77

1.6

21403.67

14510.54

e6/l

1.13

254

1950

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

467

0.81

0.77

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

190

0.70

0.76

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

140

0.65

0.76

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

206

0.72

0.76

1.2

1.4

86.08

74.44

1.09

175

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

359

1.22

0.75

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

270

0.76

0.75

1.0

1.1

—

2.93

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

929

6850

0.95

0.75

4.6

5.9

24.72

24.82

mmol/l

0.35

917

6767

(3002523) Influenza virus A Ag [Presence] in Specimen

371

0.80

0.73

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2988

21541

0.97

0.73

3.1

3.5

0.86

ug/l

0.07

2178

16067

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.62

0.73

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

549

1.17

0.72

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

101

0.63

0.71

1.2

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

462

0.82

0.71

1.1

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

145

906

1.13

0.71

1.3

29.00

67.59

titre

—

(36660697) Celiac disease serology panel - Serum

880

5917

1.05

0.70

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7883

54857

1.02

0.70

4.0

6.0

12.56

12.35

umol/l

0.59

7260

51872

(3030313) Adrenal Ab [Titer] in Serum

1.70

0.69

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.70

0.69

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

1743

11895

1.04

0.68

2.1

2.5

65.00

67.63

e9/l

2.43

1318

9075

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

122

756

1.14

0.68

1.2

1.08

1.47

nmol/l

6.41

109

687

(3044009) aPTT.lupus sensitive (LA screen)

0.54

0.68

1.0

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

326

1.21

0.67

1.5

1.8

—

(3020491) Glucose [Moles/volume] in Blood

118

732

1.14

0.66

1.9

2.3

7.42

7.26

mmol/l

0.25

490

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

135

0.68

0.65

1.0

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2488

17949

0.97

0.65

2.0

2.5

2.20

2.25

g/l

3.50

2182

16363

(3006442) Creatine [Moles/volume] in Serum or Plasma

579

0.85

0.65

2.0

1.8

94.36

99.46

umol/l

0.36

579

(3013293) Extractable nuclear Ab [Presence] in Serum

118

0.66

0.65

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

247

0.77

0.64

1.3

27.48

51.20

g/l

0.54

205

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

673

4976

0.95

0.64

1.9

2.3

3.01

3.00

g/l

0.08

535

4300

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.57

0.63

4.8

4.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

142

0.69

0.63

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.58

0.63

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

102

1.38

0.63

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

126

996

0.89

0.63

1.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.62

0.0

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

751

5052

1.05

0.61

2.2

2.5

39.88

24.06

au/ml

0.90

212

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.61

0.0

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

373

2800

0.94

0.60

2.4

2.6

16.18

15.63

1.76

171

1514

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.59

0.0

8.5

—

44.00

—

(36303858) Crystals [Presence] in Urine

0.00

0.59

0.0

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.59

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.60

0.59

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

421

0.84

0.59

3.5

6.5

24.31

24.82

mmol/l

0.48

379

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

128

1.32

0.59

2.7

2.9

46.34

38.96

umol/l

0.72

104

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.76

0.59

1.0

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

290

0.80

0.59

1.4

1.3

—

(3000285) Sodium [Moles/volume] in Blood

178

1.27

0.58

1.4

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

131

0.70

0.58

1.0

—

(3019174) dRVVT (LA screen)

0.56

0.57

1.0

1.2

—

(3014891) Appearance of Pleural fluid

262

1.21

0.56

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

218

0.77

0.56

1.2

1.3

38.32

81.13

mu/l

1.62

152

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

154

0.73

0.55

1.1

1.2

18.33

17.23

u/l

—

106

(3015183) Erythrocyte sedimentation rate

162

0.74

0.55

1.1

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

302

2274

0.93

0.55

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

102

637

1.13

0.55

1.9

2.0

18.34

28.61

umol/l

—

(3033658) Prothrombin time (PT) actual/Normal

3709

25677

1.02

0.54

3.5

4.0

80.68

82.41

3.69

3599

25075

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

144

1117

0.91

0.54

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.56

0.53

1.2

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

525

3882

0.95

0.53

1.8

2.3

0.02

0.06

g/l

1.86

439

3477

(3001964) Herpes simplex virus Ag [Presence] in Specimen

255

0.80

0.53

1.4

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

278

0.81

0.53

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

278

0.81

0.53

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

0.66

0.52

1.6

1.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

120

0.70

0.52

1.2

3.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

168

0.75

0.52

1.1

1.2

—

(4212803) Bone marrow aspirate examination

144

0.73

0.52

1.1

1.0

—

(3000991) Gas panel - Venous blood

1412

10225

0.97

0.51

4.6

6.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

315

2360

0.94

0.51

1.2

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

142

1097

0.91

0.50

1.3

1.4

175418.69

184763.86

e6/l

0.04

749

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

198

0.78

0.49

1.1

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.62

0.49

1.1

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1756

12069

1.03

0.48

4.4

3.9

—

(3024928) Oxygen saturation in Venous blood

365

2430

1.06

0.48

1.6

2.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

118

0.72

0.48

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12042

85233

0.98

0.47

6.5

7.0

42.05

41.29

mmol/mol

11.36

10651

76198

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3865

27615

0.98

0.47

2.6

3.1

34.79

37.25

u/l

0.97

3563

25778

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

327

0.84

0.47

1.0

1.1

9.29

11.92

iu/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

157

0.76

0.47

1.2

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

360

1.15

0.46

1.3

1.4

73.45

61.30

2.51

311

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

567

0.88

0.46

1.1

1.2

9.58

9.72

mmol/l

0.10

537

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

188

0.79

0.46

1.1

69.17

80.66

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

947

6458

1.03

0.45

5.9

8.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.35

0.45

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.35

0.45

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.35

0.45

1.0

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

485

3572

0.95

0.45

1.9

2.4

0.00

g/l

-0.00

411

3237

(3024869) Neuronal Ab [Presence] in Serum

218

0.81

0.45

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

483

0.87

0.44

1.3

1206.49

191.54

ug/l

0.91

271

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.68

0.44

2.0

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

271

0.83

0.44

1.1

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

186

1.21

0.43

1.2

1.1

1543.75

1676.50

miu/ml

0.26

186

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

186

0.79

0.43

1.1

1.2

77.00

77.95

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.63

0.43

2.0

3.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

178

0.79

0.43

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

162

0.78

0.42

1.0

1.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.42

0.0

2.3

—

2.52

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.42

0.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.42

0.0

2.7

—

2.79

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.53

0.41

1.4

501.80

397.30

nmol/l

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.41

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.41

0.0

2.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.41

0.0

3.5

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

0.66

0.40

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12579

88172

1.02

0.40

4.9

5.4

6.19

6.13

mmol/l

4.50

10907

77145

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

359

1.14

0.40

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

111

854

0.91

0.39

6.9

12.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1061

7673

0.97

0.39

5.6

7.4

93.06

93.66

1.89

1056

7641

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.38

1.0

—

(3010421) pH of Blood

451

3309

0.96

0.38

3.3

4.3

7.42

0.77

391

3013

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

497

3637

0.96

0.37

1.9

2.3

0.00

g/l

0.09

413

3248

(3035933) Granulocytes/100 leukocytes in Blood

0.73

0.37

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

212

0.83

0.36

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

694

4733

1.03

0.36

2.6

3.1

4.25

4.29

pmol/l

0.65

577

4029

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

276

1.15

0.36

1.3

24.76

31.70

0.68

176

(3023383) Lactate [Moles/volume] in Pleural fluid

510

0.90

0.35

1.3

4.03

3.25

mmol/l

0.92

466

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

203

0.83

0.34

1.2

1.3

39.50

399.68

u/l

0.86

138

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

582

0.91

0.34

1.4

1.8

—

(3044927) Protein electrophoresis panel - Urine

205

1528

0.94

0.34

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.68

0.33

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.67

0.33

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.67

0.33

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

818

5604

1.03

0.33

1.7

1.9

2.70

2.30

ug/l

0.26

640

4844

(44786800) Granulocytes/100 leukocytes in Body fluid

232

0.85

0.33

1.3

1.4

15.42

23.21

0.79

181

(3020961) Endomysium IgA Ab [Titer] in Serum

412

3015

0.96

0.33

1.1

399.09

201.76

titre

0.68

(3028271) Lactate [Moles/volume] in Capillary blood

304

2046

1.05

0.32

1.8

1.9

1.75

1.71

mmol/l

0.29

299

1996

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

286

1.13

0.32

2.5

7.16

7.46

mmol/l

0.32

193

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.71

0.31

1.3

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

135

1.20

0.31

4.6

5.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

468

0.90

0.31

1.1

2.6

57.95

73.54

mg/l

1.15

312

(3003129) Base excess in Capillary blood by calculation

327

0.88

0.30

1.4

1.9

0.30

0.73

mmol/l

0.23

308

(3005011) Chlamydia sp Ab [Titer] in Serum

1.26

0.30

2.1

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

622

4507

0.97

0.30

1.8

2.5

1.39

1.12

g/l

0.65

475

3726

(3027273) Bicarbonate [Moles/volume] in Venous blood

970

6676

1.02

0.29

2.9

3.5

25.28

25.13

mmol/l

0.68

932

6497

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

289

0.88

0.29

1.6

1.5

0.36

0.39

ug/l

0.15

160

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1117

7703

1.02

0.29

5.3

7.2

1.45

1.33

4.94

1111

7636

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

223

1.14

0.27

1.4

110.12

128.17

ng/l

0.52

223

(3029075) Extractable nuclear Ab panel - Serum

212

0.86

0.27

1.2

1.0

—

(3000330) Specific gravity of Urine by Test strip

900

6472

0.98

0.26

3.9

4.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

256

0.88

0.26

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

318

1.11

0.26

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.25

0.26

1.7

1.2

—

(3020650) Glucose [Presence] in Urine

181

0.86

0.25

3.2

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1621

11246

1.02

0.24

2.1

2.5

9.18

10.02

umol/l

0.76

1340

9757

(3007853) Bacteria identified in Skin by Aerobe culture

1797

12481

1.02

0.24

1.7

1.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

239

0.88

0.23

1.2

1.1

232.05

279.41

pmol/l

0.57

160

(3033923) Metanephrine [Moles/time] in 24 hour Urine

238

0.89

0.22

1.1

0.58

0.67

umol/24h

0.47

102

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

362

1.09

0.22

1.5

1.8

11.75

14.03

nmol/l

1.93

326

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.22

0.0

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.4

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.22

0.0

6.7

—

8.88

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.22

0.0

2.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

406

0.92

0.21

7.9

5.1

59.37

72.17

1.91

318

(3046861) Legionella sp Ag [Presence] in Urine

0.78

0.21

1.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

318

0.91

0.21

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

108

1.17

0.21

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

256

1866

0.97

0.21

1.5

1.6

3.23

4.83

iu/l

2.88

522

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.26

0.20

1.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1108

7681

1.02

0.20

5.4

7.3

0.72

0.66

4.96

1099

7616

(3017704) Immunofixation for Urine

116

775

1.05

0.20

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

132

0.85

0.20

2.1

1.8

65.45

1958.64

e6/l

1.81

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

132

0.85

0.20

1.0

1.3

257.73

841.65

ng/l

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.21

0.20

1.0

1.1

—

36.74

—

(3051611) Lipemic interference index of Serum or Plasma

197

1334

1.04

0.20

3.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

162

1.13

0.19

1.3

1.7

1.48

1.17

ug/l

0.29

151

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

213

0.89

0.19

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.14

0.19

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1443

10032

1.01

0.19

3.0

3.9

1.23

mmol/l

1.01

1159

8667

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.21

0.18

1.0

1.1

0.86

1.11

u/field

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

142

958

1.04

0.18

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.12

0.17

1.4

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.72

0.17

1.2

1.1

2729.80

334.55

u/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

364

0.93

0.17

1.4

1.3

5.93

15.33

umol/l

2.44

249

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.83

0.17

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.13

0.16

1.5

1.7

22.90

17.22

umol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.15

0.15

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.78

0.14

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

154

1047

1.04

0.14

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

154

1048

1.03

0.14

1.3

—

(3049717) Cytology report of Urine Cyto stain

786

5610

0.99

0.14

2.8

2.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.83

0.14

1.0

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

511

1.05

0.12

1.4

14.51

14.96

umol/l

0.16

477

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

141

0.90

0.12

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

119

0.89

0.12

1.7

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

1.12

0.11

1.1

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

213

0.93

0.11

1.1

1.2

0.66

1.64

mmol/l

1.18

132

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.17

0.11

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

133

0.90

0.11

1.3

1.1

—

(3037756) Immunofixation for Serum or Plasma

435

3111

0.98

0.11

1.4

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.87

0.11

1.3

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

436

0.95

0.11

2.5

2.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

458

1.05

0.11

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

0.89

0.11

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

521

1.04

0.10

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

103

0.89

0.10

1.0

1.1

1.78

1.65

umol/24h

0.33

103

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

650

4524

1.01

0.10

1.2

1.3

50.74

61.34

au/ml

0.54

232

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

262

0.94

0.10

1.1

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

391

0.95

0.09

1.3

1.4

16.71

20.57

0.58

321

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.15

0.09

1.6

1.3

1.20

1.06

u/field

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

447

3106

1.01

0.09

1.1

0.99

1.18

u/ml

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

669

0.97

0.09

1.6

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

583

4150

0.99

0.09

1.8

2.2

36.67

36.78

g/l

0.16

441

3456

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.14

0.09

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

150

1.08

0.09

1.2

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.08

0.09

1.2

1.1

175.33

271.22

nmol/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

106

725

1.03

0.09

3.2

2.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

144

1.08

0.08

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.80

0.07

1.7

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.02

0.07

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

111

800

0.98

0.07

2.2

1.8

288.83

314.14

mu/l

0.40

102

732

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

171

1223

0.98

0.06

2.7

2.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1417

10020

1.00

0.05

1.7

2.0

0.20

g/l

0.01

1234

9193

(3052851) Hemolysis interference index of Serum or Plasma

525

3669

1.01

0.05

3.4

3.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

244

1.04

0.04

1.1

1.2

125.67

130.33

nmol/l

0.07

179

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.10

0.04

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.92

0.04

1.2

1.1

10.00

11.49

u/l

0.18

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

105

728

1.02

0.03

1.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

677

4788

1.00

0.03

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

311

0.97

0.03

2.3

2.0

14.68

46.00

u/l

2.88

291

(3051651) Icteric interference index of Serum or Plasma

706

0.99

0.02

3.2

3.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.08

0.02

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

199

1.03

0.01

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2736

19275

1.00

0.01

2.1

2.6

11.15

11.62

umol/l

3.05

2371

17674

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.06

0.01

1.1

1.6

1.15

1.16

mmol/l

—

(3025549) Creatine [Moles/time] in 24 hour Urine

103

0.96

0.01

1.2

1.4

—

(3044941) Cell count panel - Synovial fluid

247

1744

1.00

0.00

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.97

0.00

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

144

0.98

0.00

1.4

1.7

40.60

47.00

umol/l

0.58

144

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

225

1.00

0.00

1.1

—

(3001729) Color of Synovial fluid

118

1.01

0.00

1.5

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

106

1.00

0.00

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.01

0.00

1.3

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

195

1375

1.00

0.00

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

618

1.00

0.00

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

618

1.00

0.00

1.2

1.4

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

251

1.01

0.00

1.6

93.55

115.97

ug/l

0.56

210

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.01

0.00

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.00

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.01

-0.00

1.6

1.5

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

31.00

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.94

-0.00

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

1.8

—

5.67

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.98

-0.00

1.8

1.6

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

3.44

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.4

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.88

-0.00

1.0

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: G6_ALZHEIMER_INCLAVO – Alzheimer disease, including avohilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alzheimer disease, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Alzheimer disease, including avohilmo (G6_ALZHEIMER_INCLAVO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints